Document:

Exhibit

STOCK APPRECIATION RIGHT AGREEMENT 
THIS STOCK APPRECIATION RIGHT AGREEMENT (this "Agreement") is made and entered into effective [Grant Date:Month DD, YYYY] (the “Date of Grant”) by and between InnerWorkings, Inc., a Delaware corporation (the "Company"), and [Participant Name:First Name Last Name] (the "Participant").
RECITALS
WHEREAS, the Participant has been designated by the Compensation Committee of the Board of Directors of the Company (the "Committee") to participate in the InnerWorkings, Inc. 2006 Stock Incentive Plan, as amended (the "Plan") (capitalized terms used but not otherwise defined herein shall have the meanings assigned to such terms in the Plan).
NOW, THEREFORE, in consideration of the premises and mutual covenants contained herein, and for other good and valuable consideration, the Company and the Participant agree as follows:
AGREEMENT
1. Grant.  The Company hereby grants to the Participant [Granted:SARs Granted] Stock Appreciation Rights (the "SARs") with respect to an equal number of Shares, at a Grant Price per SAR set forth below.  Each SAR entitles the Participant to receive, upon exercise thereof, a cash payment in the amount determined pursuant to Section 6 below. The SARs are granted as of the Date of Grant and are subject to all of the terms and conditions set forth herein and to all of the terms and the conditions of the Plan, which is incorporated by reference herein.  In the event of a conflict between the Plan and this Agreement, the terms of the Plan shall govern.
2. Grant Price.  The grant price per Share subject to the SARs shall be [Price:SAR Award Price], which is not less than the Fair Market Value of a Share on the Date of Grant (the “Grant Price”).
3. Term of SARs.  The SARs may, subject to the vesting and termination provisions of Sections 4 and 5 below, be exercised only during the period commencing on the Date of Grant and continuing until the close of business on the tenth anniversary of the Date of Grant (the "SAR Term").  At the end of the SAR Term, the SARs shall terminate, unless sooner terminated pursuant to Section 5 below.
4. Vesting.  The SARs shall be exercisable only to the extent that the SARs have vested.  
(a)     The SARs shall vest and become exercisable pursuant to the following schedule (provided the Participant has remained continuously in Service as of each applicable vesting date):
(i) one-quarter (1/4) of the SARs shall vest and become exercisable on the first anniversary of the Date of Grant;
(ii) an additional one-quarter (1/4) of the SARs shall vest and become exercisable on the second anniversary of the Date of Grant;
(iii) an additional one-quarter (1/4) of the SARs shall vest and become exercisable on the third anniversary of the Date of Grant; and
(iv) the final one-quarter (1/4) of the SARs shall vest and become exercisable on the fourth anniversary of the Date of Grant.
(b)     Notwithstanding anything herein to the contrary, in the event of a Change in Control, the SARs will be subject to Section 3.4 of the Plan.
5. Termination of Employment.  In the event the Participant experiences a termination of Service, the SARs shall terminate in accordance with the following:
(a) In the event the Participant’s Service is terminated by the Company for any reason other than Cause, Disability, or death, or by the Participant for "Good Reason" (if and to the extent such term is defined in a written employment or other written agreement between the Participant and the Company), SARs that are exercisable pursuant to Section 4 of this Agreement at the time of such termination of Service shall remain exercisable until the earlier of (i) the expiration of the SAR Term or (ii) one year from the date of such termination of Service.  SARs that are not exercisable at the time of such termination of Service shall expire at the close of business on the date of such termination of Service.

(b) In the event the Participant terminates Service on account of the Disability or death of the Participant, SARs that are exercisable pursuant to Section 4 of this Agreement at the time of such termination of Service shall remain exercisable until the expiration of the SAR Term.  SARs that are not exercisable at the time of such termination of Service shall expire at the close of business on the date of such termination of Service.
(c) In the event the Participant’s Service is terminated for Cause, all outstanding SARs granted to such Participant, whether or not then vested and exercisable, shall expire as of the commencement of business on the date of such termination of Service.
(d) In the event the Participant terminates Service for any reason other than those described in subsections (a), (b) and (c) of this Section 5, SARs that are exercisable pursuant to Section 4 of this Agreement at the time of such termination of Service shall remain exercisable until the earlier of (i) the expiration of the SAR Term or (ii) thirty (30) days from the date of such termination of Service.  SARs that are not exercisable at the time of such termination of Service shall expire at the close of business on the date of such termination of Service.
6. Exercise of SARs.
(a) In order to exercise the SARs, the Participant shall submit to the Secretary of the Company an instrument in writing, in a form (which may be electronic) approved by the Company, specifying the number of Shares in respect of which the SARs are being exercised. The Participant may exercise the SARs for less than the full number of Shares with respect to which the SARs are vested at any point in time; provided, however, that no partial exercise of the SARs may be with respect to any fractional Shares. Such exercise shall be effective upon receipt by the Company of such notice of exercise (the “Exercise Date”).
(b) The amount delivered to the Participant upon exercise of the SARs will be equal to the product of (i) the excess, if any, of the Fair Market Value of a Share on the Exercise Date over the Grant Price, multiplied by (ii) a number of Shares represented by the number of SARs being exercised; provided, that the amount delivered to the Participant shall be subject to withholding as described in Section 7. Any amount due to the Participant upon exercise of the SARs will be paid in cash. Subject to the terms of the Plan and this Agreement, any such payment shall be made as soon as practicable after the Exercise Date.  The Participant shall not be entitled to any earnings on the value of the amount payable for the period between the Exercise Date and the receipt of such payment.
7. Tax Withholding. The Company will have the power and the right to deduct or withhold, or require the Participant to remit to the Company, the amount necessary to satisfy federal, state, and local taxes, domestic or foreign, required by law or regulation to be withheld with respect to any taxable event arising under the Plan or this Agreement with respect to the SARs.
8. No Rights as a Stockholder. The Participant shall have no rights of a stockholder with respect to the SARs.
9. Non-Transferable.  The SARs may not be sold, assigned, transferred, pledged, hypothecated or otherwise disposed of, except by will or the laws of descent and distribution. The SARs may be exercised during the lifetime of the Participant only by the Participant or by his or her guardian or legal representative; provided, that in the event of the Participant’s death, the administrator or executor of the Participant’s estate (or such other person to whom the SARs are transferred pursuant to the Participant’s will or in accordance with the laws of descent and distribution) may exercise any vested but unexercised portion of the SARs in accordance with Section 6(b). The Committee may, in its discretion, require any such transferee, guardian or legal representative to supply it with evidence the Committee deems necessary to establish the authority of the transferee, guardian or legal representative to exercise the SARs on behalf of the Participant.
11. Securities Law Requirements.
(a) The SARs will not be exercisable in whole or in part, if exercise may, in the opinion of counsel for the Company, violate the Securities Act of 1933, as amended (or other federal or state statutes having similar requirements), as it may be in effect at that time, or cause the Company to violate the terms of the Plan.
(b) The SARs are subject to the further requirement that, if at any time the Committee determines in its discretion that the registration, listing or qualification of the Shares subject to the SARs under any federal securities law, securities exchange requirements or under any other applicable law, or the consent or approval of any governmental regulatory body, is necessary as a condition of, or in connection with, the granting of the SARs, the SARs may not be exercised in whole or in part, unless the necessary registration, listing, qualification, consent or approval has been effected or obtained free of any conditions not acceptable to the Committee.

(c) With respect to individuals subject to Section 16 of the Exchange Act, transactions with respect to the SARs are intended to comply with all applicable conditions of Rule 16b-3, or its successors under the Exchange Act.  To the extent that any provision of the SARs or action by the Committee fails to so comply, the Committee may determine, to the extent permitted by law, that the provision or action will be null and void.
12. No Obligation to Exercise. Neither the Participant nor any permissible transferee is or will be obligated by the grant of the SARs to exercise them. 
13. Restrictive Covenants.
(a) Covenants Not to Compete or Solicit. During the Participant’s Service and for a period of eighteen (18) months following the termination thereof for any reason, the Participant shall not, anywhere in the Geographic Area (as defined below), other than on behalf of the Company or a Subsidiary of the Company or with the prior written consent of the Company, directly or indirectly:
(i) perform “services” (as defined below) for (in any capacity, including, without limitation, as an employee, agent, consultant, advisor, independent contractor, proprietor, partner, officer, director or otherwise), have any ownership interest in (except for passive ownership of five percent (5%) or less of any entity whose securities have been registered under the Securities Act of 1933, as amended, or Section 12 of the Exchange Act), or participate in the financing, operation, management or control of, any firm, partnership, corporation, entity or business that engages or participates in a “competing business purpose” (as defined below);
(ii) induce or attempt to induce any customer, potential customer, supplier, licensee, licensor or business relation of the Company or a Subsidiary of the Company to cease doing business with the Company or such Subsidiary, or in any way interfere with the relationship between any customer, potential customer, supplier, licensee, licensor or business relation of the Company or a Subsidiary of the Company or solicit the business of any customer or potential customer of the Company or a Subsidiary of the Company, whether or not the Participant had personal contact with such entity; and
(iii) solicit, encourage, hire or take any other action that is intended to induce or encourage, or has the effect of inducing or encouraging, any employee or independent contractor of the Company or any Subsidiary of the Company to terminate his or her employment or relationship with the Company or any Subsidiary of the Company, other than in the discharge of his or her duties as an officer of the Company, if applicable.
For purposes of this Agreement, (A) “Geographic Area” shall mean the Participant’s country of employment and any other countries in which the Participant conducts business on behalf of the Company or a Subsidiary of the Company, (B) “services” shall mean services of the type conducted, authorized, offered, or provided by the Participant on behalf of the Company during the two (2) years prior to the termination of the Participant’s Service, and (C) “competing business purpose” shall mean the sale or provision of any marketing or printed materials, items, or other products or services that are competitive with in any manner the products or services sold or offered by the Company or a Subsidiary thereof while this Agreement is in effect.
(b) Confidentiality. The Participant shall hold in a fiduciary capacity for the benefit of the Company all secret or confidential information, knowledge or data relating to the Company or any of its Affiliates, and their respective businesses, employees, suppliers or customers, which shall have been obtained by the Participant during the Participant’s Service and which shall not be or become public knowledge (“Confidential Information”). During the Participant’s Service and after the termination thereof, the Participant shall not, without the prior written consent of the Company or as otherwise may be required by law or legal process (provided, that the Participant shall give the Company reasonable notice of such process, and the ability to contest it) or as may be necessary, in the Participant’s reasonable discretion, to discharge his or her duties to the Company, communicate or divulge any Confidential Information to anyone other than the Company and those designated by it. Notwithstanding the above, this Agreement shall not prevent the Participant from revealing evidence of criminal wrongdoing to law enforcement or prohibit the Participant from divulging Confidential Information by order of court or agency of competent jurisdiction, or from making other disclosures that are protected under the provisions of law or regulation. Nothing in this Agreement prohibits the Participant from reporting possible violations of federal law or regulation to any governmental agency or entity, including but not limited to the Department of Justice, the Securities and Exchange Commission, Congress, and any Inspector General, or making other disclosures that are protected under the whistleblower provisions of applicable law or regulation. The Participant does not need the prior authorization of the Company to make any such reports or disclosures, and the Participant is not required to notify the Company that the Participant has made such reports or disclosure.

The Participant acknowledges and agrees that the Company has provided the Participant with written notice below that the Defend Trade Secrets Act, 18 U.S.C. § 1833(b), provides an immunity for the disclosure of a trade secret to report suspected violations of law and/or in an anti-retaliation lawsuit, as follows:
(1) IMMUNITY. - An individual shall not be held criminally or civilly liable under any Federal or State trade secret law for the disclosure of a trade secret that -
(A) is made -
(i) in confidence to a Federal, State or local government official, either directly or indirectly, or to an attorney; and
(ii) solely for the purpose of reporting or investigating a suspected violation of law; or
(B) is made in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal.
(2) USE OF TRADE SECRET INFORMATION IN ANTI-RETALIATION LAWSUIT. - An individual who files a lawsuit for retaliation by an employer for reporting a suspected violation of law may disclose the trade secret to the attorney of the individual and use the trade secret information in the court proceeding, if the individual-
(A) files any document containing the trade secret under seal; and
(B) does not disclose the trade secret, except pursuant to court order.
(c) Enforcement. The covenants contained in this Section 12 shall be construed as a series of separate covenants, one for each county, city, state or any similar subdivision in any Geographic Area. Except for geographic coverage, each such separate covenant shall be deemed identical in terms to the covenant contained in the preceding sections. If, in any judicial proceeding, a court refuses to enforce any of such separate covenants (or any part thereof), then such unenforceable covenant (or such part) shall be eliminated from this Agreement to the extent necessary to permit the remaining separate covenants (or portions thereof) to be enforced. In the event that the provisions of this Section 12 are deemed to exceed the time, geographic or scope limitations permitted by applicable law, then such provisions shall be reformed to the maximum time, geographic or scope limitations, as the case may be, permitted by applicable law. If the Participant breaches any of the restrictions set forth in this Section 12 and the Company commences a legal proceeding in connection therewith, the time period applicable to each such restriction shall be tolled and extended for a period of time equal to the period of time during which the Participant is determined by a court of competent jurisdiction to be in non-compliance or breach (not to exceed the duration set forth in the applicable restriction) commencing on the date of such determination.
14. Remedies for Breach.
(a)     The Participant acknowledges and agrees that the agreements and covenants set forth in Section 12 are reasonable and necessary for the protection of the Company’s business interests, that irreparable injury will result to the Company if the Participant breaches any of the terms of said covenants, and that in the event of the Participant’s actual or threatened breach of any such covenants, the Company will have no adequate remedy at law. The Participant accordingly agrees that, in the event of any actual or threatened breach by the Participant of any of said covenants, the Company will be entitled to seek immediate injunctive and other equitable relief, without bond and without the necessity of showing actual monetary damages. Nothing in this Section 13 will be construed as prohibiting the Company from pursuing any other remedies available to it for such breach or threatened breach, including the recovery of any damages that it is able to prove.
(b)     In addition, and not in limitation of the foregoing, in the event of the Participant’s breach of any of the covenants set forth in Section 12, (i) the SARs (whether vested or unvested) shall immediately be forfeited, and (ii) the Company shall be entitled to recover the amount received upon the exercise of the SARs.
(c)     Each of the parties to this Agreement will be entitled to enforce its rights under this Agreement specifically, to recover damages by reason of any breach of any provision of this Agreement, and to exercise all other rights existing in its favor.  The Participant agrees and acknowledges that money damages will not be an adequate remedy for any breach of the provisions of this Agreement and that the Company will be entitled to specific performance and injunctive relief in order to enforce or prevent any violations of the provisions of this Agreement.

15. Plan.  The Participant hereby acknowledges receipt of a copy of the Plan.  Notwithstanding any other provision of this Agreement, the SARs are granted pursuant to the Plan, as in effect on the date of the Agreement, and are subject to the terms and conditions of the Plan, as the same may be amended from time to time; provided, however, that except as otherwise provided by the Plan, no amendment to either the Plan or this Agreement will deprive the Participant, without the Participant’s consent, of the SARs or of the Participant’s rights under this Agreement.  The interpretation and construction by the Committee of the Plan, this Agreement, the SARs, and such rules and regulations as may be adopted by the Committee for the purpose of administering the Plan, will be final and binding upon the Participant. In the event that the terms of this Agreement conflict with the terms of the Plan, the Plan shall control.
16. No Employment Rights. No provision of this Agreement or of the SARs will give the Participant any right to continue in the employ of the Company or any of its Affiliates, create any inference as to the length of employment of the Participant, affect the right of the Company or its Affiliates to terminate the employment of the Participant, with or without Cause, or give the Participant any right to participate in any employee welfare or benefit plan or other program of the Company or any of its Affiliates.
17. Changes in Company’s Capital or Organizational Structure.  The existence of the SARs shall not affect in any way the right or authority of the Company or its shareholders to make or authorize any or all adjustments, recapitalizations, reorganizations or other changes in the Company’s capital structure or its business, or any merger or consolidation of the Company, or any issue of preferred Shares ahead of or affecting the Shares or the rights thereof, or the dissolution or liquidation of the Company, or any sale or transfer of all or any part of its assets or business, or any other act or proceeding, whether of a similar character or otherwise.
18. References.  References herein to rights and obligations of the Participant shall apply, where appropriate, to the Participant’s legal representative or guardian without regard to whether specific reference to such legal representative or guardian is contained in a particular provision of this Agreement or the Plan.
19. Governing Law; Construction.  This Agreement and the SARs will be governed by, and construed and enforced in accordance with, the laws of the State of Illinois without regard to conflicts of law principles. The jurisdiction and venue for any disputes arising under, or any action brought to enforce (or otherwise relating to), this Agreement will be exclusively in the courts in the State of Illinois, Cook County, including the Federal Courts located therein (should Federal jurisdiction exist). Notwithstanding anything in this Agreement to the contrary, either party can seek injunctive relief in any court of competent jurisdiction. Common nouns and pronouns shall be deemed to refer to the masculine, feminine, neuter, singular and plural, as the context requires.
20. Entire Agreement.  This Agreement, together with the Plan and any other agreements incorporated by reference, constitutes the entire obligation of the parties with respect to the subject matter of this Agreement and supersedes any prior written or oral expressions of intent or understanding with respect to such subject matter (provided, that this Agreement shall not supersede any written employment agreement or other written agreement between the Company and the Participant, including, but not limited to, any written restrictive covenant agreements). Notwithstanding the foregoing, Section 12(a) hereof hereby supersedes any non-competition and/or non-solicitation provision set forth in any previous Award Agreement under the Plan between the Company and the Participant.   The Participant represents that, in executing this Agreement, he does not rely and has not relied upon any representation or statement not set forth herein made by the Company with regard to the subject matter, bases or effect of this Agreement or otherwise.
21. Amendment.  This Agreement may be amended as provided in the Plan.
22. Waiver; Cumulative Rights.  The failure or delay of either party to require performance by the other party of any provision of this Agreement will not affect its right to require performance of such provision unless and until such performance has been waived in writing.  Each right under this Agreement is cumulative and may be exercised in part or in whole from time to time.
23. Counterparts.  This Agreement may be executed in counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument.
24. Notices.  Any notices required or permitted under this Agreement must be in writing and may be delivered personally or by mail, postage prepaid, addressed to (a) the Company at InnerWorkings, Inc., 600 West Chicago Avenue, Suite 850, Chicago, IL 60654, Attention: Corporate Secretary and (b) the Participant at the Participant’s address as shown on the Company’s payroll records, or to such other address as the Participant, by notice to the Company, may designate in writing from time to time.
25. Headings.  The headings in this Agreement are for reference purposes only and will not affect the meaning or interpretation of this Agreement.

26. Severability.  If any provision of this Agreement or the application of any such provision to any party or circumstances shall be determined by any court of competent jurisdiction to be invalid and unenforceable to any extent, the remainder of this Agreement or the application of such provision to such person or circumstances other than those to which it is so determined to be invalid and unenforceable, shall not be affected thereby, and each provision hereof shall be validated and shall be enforced to the fullest extent permitted by law.
27. No Strict Construction.  The language used in this Agreement will be deemed to be the language chosen by the parties to express their mutual intent, and no rule of strict construction will be applied against any party.
28. Successors and Assigns.  This Agreement will inure to the benefit of and be binding upon each successor and assign of the Company.  All obligations imposed upon the Participant or a representative, and all rights granted to the Company under this Agreement, will be binding upon the Participant’s or the representative’s heirs, legal representatives and successors.
29. Tax Consequences.  The Participant shall be responsible for all taxes required to be paid under applicable tax laws with respect to the SARs.
30. No Guarantee of Future Awards. This Agreement does not guarantee the Participant the right to or expectation of future Awards under the Plan or any future incentive plan adopted by the Company.
31. Incentive Compensation Recoupment. Notwithstanding anything in the Plan or in this Agreement to the contrary, the SARs shall be subject to any compensation recovery and/or recoupment policy adopted by the Company to comply with applicable law, including, without limitation, the Dodd-Frank Wall Street Reform and Consumer Protection Act, or to comport with good corporate governance practices, as such policies may be adopted and/or amended from time to time.
[signature page follows]

            IN WITNESS WHEREOF, the parties have executed this Agreement as of the date and year set forth above. 

	
							
	INNERWORKINGS, INC.:
	 
	PARTICIPANT:

	 
	 
	 
	 
	 
	 
	 

	By:
	 
	 
	 

	Name:
	Oren Azar
	 
	 

	Title:
	General Counsel
	 
	 

	 
	 
	 
	 
	 
	 
	 

2006 Stock Incentive Plan as Amended Sept 6 2018
INWK Prospectus Sept 2018EX-10.1

 Exhibit 10.1 

Execution Version 

AMENDED & RESTATED EMPLOYMENT AGREEMENT (“Agreement”) dated as of August 8, 2019 (the “Effective Date”), by
and between HENRY SCHEIN, INC., a Delaware corporation (the “Company”), and STANLEY M. BERGMAN (“Bergman”). 
 WHEREAS,
Bergman is currently Chairman of the Board of Directors and Chief Executive Officer of the Company, and Bergman and the Company previously had entered into an Amended and Restated Employment Agreement dated as of December 31, 2016 (the
“Prior Agreement”); 
 WHEREAS, the Company recognizes that Bergman has made substantial contributions to the success of the
Company over a long period of time and desires to assure the Company of Bergman’s continued service and Bergman desires to continue to perform services for the Company; and 

WHEREAS, Bergman and the Company wish to amend and restate the Prior Agreement in the form set forth below. 

In consideration of the agreements herein after set forth, the Company and Bergman agree as follows: 

 

	 	1.	 EMPLOYMENT 

1.1    CAPACITY; DUTIES. The Company hereby continues to employ Bergman as the Company’s Chairman of the Board of
Directors and Chief Executive Officer. Bergman shall have general supervision over the business and affairs of the Company and its subsidiaries, shall report and be responsible only to, and subject to the supervision of, the Board of Directors of
the Company (the “Board of Directors”), and shall have powers and authority superior to those of any other officer or employee of the Company or any of its subsidiaries. The Board of Directors may with Bergman’s consent, which consent
may be withheld in his reasonable discretion, confer the title of President upon another person without any diminution in the compensation or benefits payable to Bergman hereunder. Subject to Section 6(b), Bergman may serve on the board of
directors of any other corporation, or may be involved in civic or charitable activities and may manage his personal investments, so long as such service does not interfere with his duties to the Company or its subsidiaries and such other
corporation is not a supplier or customer of the Company and does not engage in any business that is competitive with the business of the Company. Bergman accepts the employment described herein and agrees to devote his full business time and effort
thereto, and to perform those duties normally attributable to the positions for which he is employed hereunder. 

1.2    EMPLOYMENT PERIOD. Bergman’s employment shall be for the period (the “Employment Period”) commencing
on the Effective Date, and ending on the earlier of (i) December 31, 2022, as such date may be extended as provided below, or (ii) the date on which Bergman’s employment is terminated earlier pursuant to Section 4. The
Employment Period may be extended by the Company for successive one-year periods by giving Bergman notice (an “Extension Notice”) at least six months prior to the date that the then applicable
Employment Period is to expire. Notwithstanding the preceding sentence, the Employment Period shall not be 

 
extended if Bergman, within 90 days after any Extension Notice is given, advises the Company that he chooses not to extend the Employment Period. The date on which the Employment Period is
scheduled to expire pursuant to whichever shall be the later of the date set forth in clause (i) above or the extended date as provided above is hereinafter referred to as the “Employment Expiration Date.” 

 

	 	2.	 COMPENSATION 

2.1    BASE SALARY. During the Employment Period, as compensation for Bergman’s employment hereunder, Bergman shall
receive a base salary at the rate of $1,470,000 per annum, payable in accordance with the Company’s normal payroll practices for its senior executive officers from time to time in effect. The base salary may be increased by such amounts
and at such times as shall be determined by the Board of Directors or the Compensation Committee of the Board of Directors (the “Compensation Committee”) from time to time, in its sole discretion. (The base salary, as it may be increased
from time to time, is hereinafter referred to as the “Base Salary.”) 
 2.2    INCENTIVE COMPENSATION. During
the Employment Period, Bergman shall be eligible to receive, in addition to his Base Salary, incentive compensation (“Incentive Compensation”) as follows: with respect to each year during the Employment Period, the Compensation Committee
shall, after consultation with Bergman, establish a target annual Incentive Compensation opportunity for Bergman, to be expressed as a percentage of the Base Salary for such year, and performance criteria consistent with such performance-based
criteria as are applicable to other Company senior management, it being understood that for the 2019 calendar year, Bergman’s Incentive Compensation shall be as established for the 2019 calendar year under the Prior Agreement. All Incentive
Compensation shall be paid as soon as practicable after the amount of such compensation has been finally determined, and in all events during the calendar year immediately following the calendar year with respect to which the Incentive Compensation
was earned. 
 2.3    ADDITIONAL COMPENSATION. Nothing contained herein shall limit or otherwise restrict the Board of
Directors from granting to Bergman at any time and from time to time such additional compensation as may be recommended from time to time by the Compensation Committee. 

2.4    EXPENSES. The Company shall promptly reimburse Bergman for all expenses reasonably incurred by him in the
performance of his duties under this Agreement in accordance with the Company’s general policies and practices for senior executive officers in effect from time to time; provided that in no event shall any such reimbursement be made later than
the later of (i) the 15th day of the third month following the end of the calendar year in which the applicable expense is incurred or (ii) the 15th day of the third month following the end of the fiscal year in which the applicable expense is incurred. 

  
 2 

	 	3.	 BENEFITS 

3.1    BENEFITS. During the Employment Period, Bergman shall be entitled to participate in all benefit, welfare,
perquisite, equity and other similar plans, policies and programs, in accordance with the terms as are generally provided from time to time by the Company for its senior management employees and for which Bergman is eligible. Unless Bergman’s
employment shall have been terminated for Cause (in the manner and as defined in Section 4.3), during the period commencing immediately after Bergman’s termination of employment for any reason and continuing (x) as to Bergman, for the
life of Bergman, and (y) as to Bergman’s spouse, for the life of his spouse, the Company shall continue the participation of Bergman and his spouse in all health and medical benefit plans, policies and programs in effect from time to time
with respect to the senior executive officers of the Company and their families generally (at the same levels and at the same cost, if any, as provided to the senior executive officers of the Company generally immediately prior to his date of
termination). Notwithstanding the foregoing, in the event the plan under which Bergman and his spouse were receiving health benefits immediately prior to Bergman’s date of termination is not fully-insured or would trigger excise taxes or other
penalties on the Company if provided to Bergman and/or his spouse after Bergman’s date of termination, then the Company shall either (A) provide health coverage to Bergman and his spouse pursuant to a fully-insured replacement policy or
(B) in lieu of such health coverage pay Bergman (or to his spouse, as applicable, in the event of his death) annual cash payments equal to the cost to Bergman (and/or his spouse) to obtain a replacement policy (i.e., the premium costs),
as determined on the termination date (adjusted for increase in the cost-of-living index, as defined in Treasury Regulation
Section 1.401(a)(9)-6, Q&A-14(b)(2)); in either case for the remaining lives of Bergman and his spouse. In all cases, the annual cash payments described above
(if applicable), will be paid on each anniversary of Bergman’s date of termination, commencing with the one-year anniversary of such date. The provision of benefits under this Section 3.1 following
Bergman’s termination of employment shall be subject to Section 5.7 hereof. 
 3.2    VACATION. During each
calendar year during the Employment Period, Bergman shall be entitled to four weeks of vacation (which shall be prorated for partial years during the Employment Period) and such other number of personal days generally afforded to senior executive
officers of the Company. 
 3.3    AUTOMOBILE. During the Employment Period, the Company shall provide Bergman with
first priority, non-exclusive use of a car and driver on the same basis as immediately prior to the Effective Date. At Bergman’s option, the Company shall provide Bergman with the use of a new automobile
during the Employment Period, similarly equipped to that last provided to him under the Prior Agreement, and shall pay the costs of fuel, maintenance, repairs and insurance. If Bergman’s employment hereunder is terminated by the Company without
Cause (as defined in Section 4.3), by the Company choosing not to extend the Employment Period, upon Bergman’s Disability, by Bergman for Good Reason pursuant to Section 4.1(c)(i), or by Bergman voluntarily pursuant to
Section 4.1(c)(ii), the Company shall continue the arrangements in effect immediately prior to his termination of employment until the second anniversary of Bergman’s date of termination. If Bergman’s employment is terminated by the
Company without Cause, by the Company choosing not to extend the Employment Period, or by Bergman for Good Reason pursuant to Section 4.l(c)(i), in any such case within two years after the date of a Change in Control, the Company shall continue
the transportation arrangements in effect immediately prior to his termination of employment until the last day of the second calendar year following the calendar year in which Bergman’s date of termination occurs, and (ii) shall pay on
the second anniversary of Bergman’s date of termination a lump 

  
 3 

 
sum in cash equal to the value of the applicable benefits specified in the prior sentence for the period from the last day of the second calendar year following the calendar year on which the
termination date occurs until the third anniversary of his date of termination. The provision of benefits under this Section 3.3 following Bergman’s termination of employment shall be subject to Section 5.7 hereof. 

3.4    CONVERSION OF BENEFITS. During the Employment Period, Bergman shall be entitled to the same conversion privileges
(including but not limited to cash conversions) with regard to the Company’s benefit plans, policies and programs in which Bergman is entitled to participate under Section 3.1 as may be generally offered from time to time by the Company to
its senior executive officers; provided that in the event of a cash conversion, the payment of such cash conversion shall be made no later than the later of (i) the 15th day of the third
month following the end of the calendar year in which the benefit is offered to senior executive officers or (ii) the 15th day of the third month following the end of the fiscal year in which
the benefit is offered to senior executive officers. 
 3.5    RSU AWARDS. Simultaneously with the Compensation
Committee’s approval of this Agreement and as an inducement for Bergman to enter into this Agreement, the Compensation Committee shall approve two restricted stock unit (“RSU”) grants to Bergman under the Company’s 2013 Stock
Incentive Plan (As Amended and Restated Effective as of May 14, 2013), to be granted at the time specified in Section 3.5, subject to Bergman’s execution of this Agreement and continued employment through the actual grant date
(“RSU Awards”). The RSU Awards shall consist of a grant that vests on the basis of the continued employment over a time-based vesting period, substantially in the form annexed to this Agreement as Exhibit
A-1 (the “Time-Based RSU Award”) and a grant that vests on the basis of continued employment and the achievement of performance targets, substantially in the form annexed to this Agreement as
Exhibit A-2 (the “Performance-Based RSU Award”). The number of RSUs granted under each of the Time-Based RSU Award and the Performance-Based RSU Award shall equal $3.225 million divided
by the 20-trading day volume weighted average price of the Company’s common stock for the period immediately prior to the date of grant. The RSU Awards shall be automatically granted, without further
action of the Compensation Committee, on the first business day immediately following the twentieth (20th) trading day after the Effective Date, subject in all cases to Bergman’s continued
employment through the actual grant date of the RSU Awards. In the event of Bergman’s death or Disability (pursuant to Section 4.2) prior to the grant of the RSU Awards, the Company shall make a lump sum payment in the amount of
$6.45 million to Bergman’s spouse, or if Bergman’s spouse predeceases him, then to his estate, within thirty (30) days following the date of death or Disability, as applicable. Any payment made pursuant to the foregoing sentence
shall be in lieu of the grant of the RSU Awards, and, in the event that a payment is made pursuant to the foregoing sentence, any rights that Bergman, Bergman’s spouse or Bergman’s estate may have with respect to the RSU Awards shall be
extinguished in their entirety. 
  

	 	4.	 TERMINATION 

4.1    TERMINATION OF EMPLOYMENT. Bergman’s employment (and the Employment Period) shall terminate prior to the
Employment Expiration Date upon the occurrence of any of the following events: 
 (a)    upon
Bergman’s death or Bergman’s Disability (pursuant to Section 4.2); or 

  
 4 

 (b)    (i) by action of the Company for Cause; or
(ii) by action of the Board of Directors without Cause upon 90 days’ prior written notice to Bergman; or 

(c)    by Bergman (i) following the occurrence of an event that constitutes Good Reason, as
hereinafter defined, or (ii) voluntarily upon 180 days prior written notice to the Company. 
 A “Change in Control” shall be
deemed to occur upon any of the following: 
 (A)    acquisition of “beneficial ownership” (within the meaning
of Rule 13d-3 promulgated under the Securities and Exchange Act of 1934, as amended (the “Act”)) by any one “person” (as such term is defined in Section 3(a)(9) of the Act) or by any
two or more persons deemed to be one “person” (as used in Section 13(d) or 14(d) of the Act)(each referred to as a “Person”) excluding the Company, any subsidiary of the Company and any employee benefit plan sponsored or
maintained by the Company or any subsidiary of the Company (including any trustee of any such plan acting in his or its capacity as trustee), of 33% or more of the combined total voting power of the then-outstanding voting securities of the Company
(the “Outstanding Voting Securities”) without the prior express approval of the Board of Directors; 

(B)    acquisition of “beneficial ownership” by any Person excluding the Company, any subsidiary of the Company
and any employee benefit plan sponsored or maintained by the Company or any subsidiary of the Company (including any trustee of any such plan acting in his or its capacity as trustee), of more than 50% of the combined total voting power of the then
Outstanding Voting Securities; 
 (C)    directors elected to the Board of Directors over any 24-month period (except in the case of a Change in Control referred to in Section 5.4(c), a twelve-month period) not nominated by the Company’s Nominating & Corporate Governance Committee (or a
committee of the Board of Directors performing functions substantially similar to such committee) represent 30% (except in the case of a Change in Control referred to in Section 5.4(c), a majority) or more of the total number of directors
constituting the Board of Directors at the beginning of the period, (or such nomination results from an actual or threatened proxy contest); 

(D)    any merger, consolidation or other corporate combination of the Company (a “Transaction”), other than
(i) a Transaction involving only the Company and one or more of its subsidiaries, or (ii) a Transaction immediately following which (x) the stockholders of the Company immediately prior to the Transaction continue to be the beneficial
owners of securities of the resulting entity representing more than 60% of the voting power in the resulting entity, in substantially the same proportions as their ownership of Outstanding Voting Securities immediately prior to the Transaction and
(y) individuals who were members of the Board of Directors as of the Effective Date plus any additional directors nominated by the Company’s Nominating & Corporate Governance Committee (or a committee of the Board of Directors
performing functions substantially similar to such committee) prior to the execution of the agreement effectuating the Transaction constitute at least a majority of the members of the board of directors of the resulting entity; and 

  
 5 

 (E)    upon the sale of all or substantially all of the consolidated
assets of the Company, other than (i) a distribution to stockholders, or (ii) a sale immediately following which (x) the stockholders of the Company immediately prior to the sale are the beneficial owners of securities of the
purchasing entity representing more than 60% of the voting power in the purchasing entity, in substantially the same proportions as their ownership of Outstanding Voting Securities immediately prior to the Transaction and (y) individuals who
were members of the Board of Directors as of the Effective Date plus any additional directors nominated by the Company’s Nominating & Corporate Governance Committee (or a committee of the Board of Directors performing functions
substantially similar to such committee) prior to the execution of the agreement effectuating the Transaction constitute at least a majority of the members of the board of directors of the purchasing entity. 

Solely for purposes of Section 5.4(c), no Change in Control shall be deemed to have occurred unless the circumstances of such Change in Control would be
treated as having resulted in the occurrence of a “change in control event” as such term is defined in Treasury Regulation Section 1.409A-3(i)(5)(i). 

A “Good Reason” event shall have occurred upon the taking of any of the following actions, without Bergman’s written consent;
provided that a Good Reason event shall not be deemed to have occurred unless Bergman shall have given written notice to the Company specifying the Good Reason event within 90 days of the occurrence of such event: 

 

	 	(a)	 a material reduction or material adverse change in Bergman’s responsibilities, duties, positions or
authority, as provided in the Agreement, including, the failure to appoint Bergman to, or to continue Bergman in, any position to which he is required to be appointed under this Agreement. 

 

	 	(b)	 any failure by the Company to provide the compensation, or any failure by the Company to provide the material
benefits, agreed to be provided under this Agreement; provided, however, that any reduction in benefits generally applicable to senior management employees shall not constitute Good Reason; 

 

	 	(c)	 any change in location of the Company’s principal executive offices outside of the New York metropolitan
area (which shall consist solely of New York City, Long Island and any other location within 35 miles of the Company’s current principal executive offices) or any change in the principal location at which Bergman is required to perform his
duties under this Agreement to a location other than the Company’s principal executive offices; 

  

	 	(d)	 any failure of the Company to obtain the express assumption of this Agreement as provided in Section 9(a)
or 9(b), unless such assumption occurs by operation of law; 

  
 6 

 provided, however, that (i) a “Good Reason” event will not include acts which
are cured by the Company within 30 days from receipt by it of a written notice from Bergman identifying in reasonable detail the act or acts constituting “Good Reason,” and (ii) if the Company has failed to cure as provided above, a
“Good Reason” event will not exist unless Bergman has thereafter given notice of termination for Good Reason within 30 days after the earlier of the expiration of the 30-day cure period or the
Company’s notice to Bergman that it will not cure such Good Reason event. 
 4.2    DISABILITY. If, by reason of
physical or mental disability, Bergman (i) is unable to carry out the material duties he has agreed to carry out under this Agreement for more than 180 days in any twelve-month period or (ii) is expected to be unable to carry out his
duties for such period as certified by a Licensed Physician (“Disability”), the Employment Period shall terminate hereunder. A “Licensed Physician” shall be any qualified physician licensed to practice medicine in the State of
New York as shall be mutually agreed by the Company and Bergman (or his representatives), such approval not to be unreasonably withheld or delayed. Bergman shall submit to an examination by a physician for purposes of the preceding provisions upon
the request of the Board of Directors. During any period of Disability prior to such termination, Bergman shall continue to receive all compensation and other benefits provided herein as if he had not been disabled at the time, in the amounts and in
the manner provided herein, provided that the Company shall be entitled to a credit against such amounts with regard to the amount, if any, paid to Bergman for such period under any disability plan of the Company. 

4.3    CAUSE. For purposes of this Agreement, the term “Cause” shall be limited to (i) action or omission
by Bergman involving willful malfeasance or willful misconduct having a material adverse effect on the Company (whether economically or as to reputation), (ii) Bergman being convicted of, or pleading nolo contendere to, a felony (other
than resulting from a traffic violation or like event) or being convicted of any other crime involving intentional dishonesty or fraud, (iii) any other action by Bergman constituting a material breach of Section 6 of this Agreement which
is not cured within 30 days after notice from the Company. In the case of (i) above, no act or omission by Bergman shall be considered willful if it is done or omitted in good faith and with a reasonable belief that it was in the best interests
of the Company. Termination by the Company for Cause pursuant to (i) or (iii) above will not be effective unless the Board of Directors has voted to terminate Bergman for Cause at a meeting of the Board of Directors called for such purpose
after Bergman has been afforded at least three days notice of the meeting and an opportunity to be heard at a meeting of the Board of Directors; provided, however, that the Board of Directors may suspend Bergman with pay and benefits
pending such Board of Directors meeting. 
  

	 	5.	 CONSEQUENCES OF TERMINATION 

5.1    DEATH. If Bergman’s employment hereunder is terminated by reason of Bergman’s death, the Company shall
have no further obligation to Bergman under this Agreement except that, subject to Section 5.7 hereof, Bergman’s heirs or estate shall be paid those obligations accrued hereunder to the date of his death, consisting only of
(a) Bergman’s unpaid Base Salary to the extent unpaid through the date of termination, (b) the annual Incentive Compensation due to Bergman, if any, for the last full fiscal year of the Company ending prior to the date of termination
(if not previously paid), (c) the product of (i) the annual Incentive Compensation payable to Bergman for the fiscal year of the Company (based on the actual achievement of the specified goals) in which Bergman’s date of termination occurs
multiplied by 

  
 7 

 
(ii) a fraction, the numerator of which is the number of days in such fiscal year during which Bergman was employed by the Company, and the denominator of which is 365, (d) any accrued and unpaid
vacation pay, and (e) to the extent permitted under this Agreement, any other amounts or benefits owing to Bergman or his beneficiaries under the then applicable benefit plans, policies and programs of the Company. (All amounts determined
pursuant to the provisions of clauses (a) through (e) above are hereinafter referred to as “Accrued Obligations”.) Unless otherwise required by any benefit plan qualified under Section 401(a) of the Internal Revenue Code of 1986,
as amended (the “Code”) (any such plan hereinafter referred to as a “Qualified Plan”), the Accrued Obligations described in clauses (a), (b), (d) and (e) above shall be paid to Bergman’s estate or designated
beneficiaries, as the case may be, in a lump sum (to the extent such obligations are able to be paid in a lump sum, under the terms of the plan for which such obligation arose) in cash within 15 business days after the date of Bergman’s death,
and, otherwise, in accordance with the terms of the applicable plan or applicable law. The Accrued Obligation described in clause (c) above shall be paid in a lump sum to Bergman’s estate or designated beneficiaries, as the case may be, at
the time specified in the last sentence of Section 2.2. Nothing in this Section 5.1 shall be deemed to affect the right of Bergman’s spouse to receive the applicable benefits referred to in Section 3.1. 

5.2    COMPANY TERMINATION FOR CAUSE; RESIGNATION OTHER THAN FOR GOOD REASON; BERGMAN
NON-RENEWAL. If Bergman’s employment hereunder is terminated by the Company for Cause, by Bergman voluntarily pursuant to Section 4.1(c)(ii), or by Bergman by
non-renewal pursuant to Section 1.2, the Company shall have no further obligation to Bergman under this Agreement, except that, unless otherwise required by any Qualified Plan, Bergman shall be paid all
Accrued Obligations to the date of termination (other than the obligations specified in clauses (b) and (c) of Section 5.1) in a lump sum (to the extent such obligations are able to be paid, under the terms of the plan for which such
obligation arose, in a lump sum) in cash within 15 business days after the date of termination, and, otherwise, in accordance with the terms of the applicable plan or applicable law. Bergman shall not be entitled to receive the amounts specified in
clauses (b) and (c) of Section 5.1. Nothing in this Section 5.2 shall be deemed to affect the right of Bergman or his spouse, as applicable, to receive the applicable benefits referred to in Sections 3.1, 3.3 and 5.5, unless
Bergman’s employment has been terminated by the Company for Cause. 
 5.3    COMPANY TERMINATION WITHOUT CAUSE OR
DUE TO DISABILITY; RESIGNATION FOLLOWING GOOD REASON; COMPANY NON-RENEWAL. Subject to Section 5.4(c), if Bergman’s employment hereunder is terminated due to Disability pursuant to Section 4.2 or
by the Company without Cause, or by Bergman for Good Reason pursuant to Section 4.1(c)(i) above, or if the Company at any time chooses not to extend or not to continue to extend the Employment Period, in each case prior to the occurrence of a
Change in Control, subject to Section 5.7 hereof, the Company shall have no further obligation to Bergman under this Agreement except that: 

(a)    Unless otherwise required by any Qualified Plan, Bergman shall be paid the Accrued Obligations to
the date of termination (other than the obligations specified in clauses (b) and (c) of Section 5.1) in a lump sum (to the extent such obligations are able to be paid in a lump sum, under the terms of the plan for which such obligation
arose) in cash within 15 business days after the date of termination, and, 

  
 8 

 
otherwise, in accordance with the terms of the applicable plan or applicable law; provided, that the obligations specified in clauses (b) and (c) of Section 5.1 shall be paid in a lump
sum in cash at the time specified in the last sentence of Section 2.2. 
 (b)    Bergman shall be
paid, as severance pay, on the first payroll date immediately following the six-month anniversary of his date of termination: 
  

	 	(i)	 in a lump sum in cash, an amount equal to 200% of Bergman’s then annual Base Salary plus, in a lump sum in
cash, an amount equal to 200% of Bergman’s average annual Incentive Compensation paid with respect to the immediately preceding three fiscal years of the Company ending prior to the date of termination, provided that, in the event that
Bergman’s employment is terminated following the end of the most recently completed fiscal year, but prior to the payment of the Incentive Compensation with respect to such year, solely for purposes of this Section 5.3(b)(i), the Incentive
Compensation for such fiscal year shall be the higher of (x) target level of Incentive Compensation for such year, and (y) Incentive Compensation for such year based on actual performance; and 

 

	 	(ii)	 in a lump sum in cash, an amount equal to the Make-Up Pension Payment
(as defined below). For purposes of this Agreement, the “Make-Up Pension Payment” shall mean with respect to each “pension plan” (as such term is defined in Section 3(2)(A) of the
Employee Retirement Income Security Act of 1974, as amended) of the Company (or its subsidiaries) in which Bergman participated or had a benefit under at the date of termination, the value of the excess of (A) the fully vested value of the
benefit to him under such plan, assuming additional credit for service for all purposes under such plan for the period from the date of termination through the Employment Expiration Date (the “Remaining Term”), continuation of
Bergman’s Base Salary for the Remaining Term, and that there are no earnings on plan funds in defined contribution type plans for any period after the date of termination, over (B) Bergman’s vested accrued benefits pursuant to the
provisions of each respective plan on the date of termination. (For purposes of calculating the Make-Up Pension Payment, the value of the excess shall be calculated using a discount rate equal to the
applicable federal rate (as defined in Code Section 1274) in effect on the date of termination of employment and no other actuarial assumptions). Notwithstanding the foregoing, for purposes of any termination of employment occurring

  
 9 

	 	
during the Employment Period, the “Remaining Term” under this clause (ii) shall mean the period from the date of termination through the immediately succeeding December 31.

 (c)    Nothing in this Section 5.3 shall be deemed to affect the right of Bergman
or his spouse, as applicable, to receive the applicable benefits referred to in Sections 3.1, 3.3 and 5.5. 

(d)    With respect to an amount due to Bergman pursuant to Section 5.3(b)(i), the Company shall be
entitled to a credit against such amount with regard to the amount, if any, payable to Bergman for such period under any disability plan of the Company. 

5.4    TERMINATION OF EXECUTIVE IN CONNECTION WITH A CHANGE IN CONTROL. If Bergman’s employment is terminated by the
Company without Cause or by Bergman for Good Reason pursuant to Section 4.1(c)(i) within two years following a Change in Control, subject to Section 5.7 hereof, the Company shall have no further obligation to Bergman under this Agreement
except that: 
 (a)    Unless otherwise required by any Qualified Plan, Bergman shall be paid all Accrued
Obligations (other than the obligations specified in clauses (b) and (c) of Section 5.1) to the date of termination in a lump sum (to the extent such obligations are able to be paid in a lump sum, under the terms of the plan for which such
obligation arose) in cash within 15 business days after the date of termination and, otherwise, in accordance with the terms of the applicable plan or applicable law; provided, that the obligations specified in clauses (b) and (c) of
Section 5.1 shall be paid in a lump sum in cash at the time specified in the last sentence of Section 2.2. 

(b)    Bergman shall be paid, as severance pay, on the first payroll date immediately following the six-month anniversary of his date of termination: 
  

	 	(i)	 in a lump sum in cash, an amount equal to 300% of Bergman’s then annual Base Salary plus, in a lump sum in
cash, an amount equal to 300% of Bergman’s annual Incentive Compensation recommended by the Compensation Committee to be paid or payable with respect to whichever of the immediately preceding two fiscal years of the Company ending prior to the
date of termination was higher; and 

  

	 	(ii)	 in a lump sum in cash, an amount equal to the Make-Up Pension Payment
(as defined above). 

 (c)    In the event Bergman’s employment is terminated by
the Company without Cause (i) within 90 days prior to the occurrence of a Change in Control, or (ii) after the first public announcement of the pendency of a Change in Control (but on or prior to a Change in Control), Bergman shall be
paid, as additional severance pay, on the 

  
 10 

 
first payroll date immediately following the later of the six-month anniversary of his date of termination and the date of the occurrence of the Change in
Control, a lump sum cash amount equal to the sum of: 
  

	 	(i)	 the excess, if any, of (A) 300% of Bergman’s annual Base Salary at the rate in effect immediately
preceding such termination of employment, plus 300% of Bergman’s annual Incentive Compensation recommended by the Compensation Committee to be paid or payable with respect to whichever of the immediately preceding two fiscal years of the
Company ending prior to the date of termination was higher, over (B) the amount paid or payable to Bergman pursuant to Section 5.3(b)(i) (whether or not such amount has then been paid); and 

 

	 	(ii)	 the excess, if any, of (A) the aggregate per share cash consideration, and the fair market value on such
date of the aggregate per share non-cash consideration, paid or payable to the Company’s common stockholders in the transaction which is the basis for the Change in Control, (or if no such consideration
was then payable, the last trading price of the Company’s common stock on the day immediately preceding the date of the event that resulted in the occurrence of the Change in Control), over (B) the strike price per share that would have
been required to be paid in order to exercise each tranche of unvested options that expired at the time of Bergman’s prior termination of employment, times the number of shares of Common Stock covered by each such tranche (such calculation to
be performed separately for each tranche with a different strike price, and the aggregate amounts so calculated being the amount required to be paid under this clause (ii)). 

The amounts provided for under this Section 5.4(c) are in addition to, and not in lieu of, the amounts provided for under
Section 5.3. 
 (d)    Nothing in this Section 5.4 shall be deemed to affect the right of
Bergman or his spouse, as applicable, to receive the applicable benefits referred to in Sections 3.1, 3.3 and 5.5. 

(e)    In the event that Bergman shall become entitled to the payments and/or benefits provided by this
Section 5.4 or any other amounts (whether pursuant to the terms of this Agreement, including Section 5.3, or any other plan, arrangement or agreement with the Company or any of its affiliates) (collectively the “Company
Payments”) and such Company Payments will be subject to the tax (the “Excise Tax”) imposed by Section 4999 of the Code (or any similar tax that may hereafter be imposed), then the Company Payments shall be either
(A) delivered in full or (B) delivered as to 

  
 11 

 
such lesser extent, as would result in no portion of such amounts being subject to the Excise Tax, whichever of the foregoing results in the receipt by Bergman on a net after-tax basis of the greatest amount, notwithstanding that all of some of the amounts may be taxable under Code Section 4999. If a reduction is to occur pursuant to clause (B) of the prior sentence,
unless an alternative election is permitted by, and does not result in taxation under, Code Section 409A and timely elected by Bergman, the Company Payments shall be cutback to an amount that would not give rise to any Excise Tax by reducing
payments and benefits in the following order: (1) accelerated vesting of restricted stock awards, to the extent applicable; (2) accelerated vesting of stock options, to the extent applicable; (3) payments under Section 5.4(b)(i)
or 5.4(c)(i) hereof, as applicable; (4) payments under Section 5.4(b)(ii) hereof, if applicable; and (5) continued health insurance under Section 3.1 hereof. 

(f)    For purposes of determining whether any of the Company Payments will be subject to the Excise Tax
and the amount of such Excise Tax, (i) the Company Payments shall be treated as “parachute payments” within the meaning of Section 280G(b)(2) of the Code, and all “parachute payments” in excess of the “base
amount” (as defined under Section 280G(b)(3) of the Code) shall be treated as subject to the Excise Tax, unless and except to the extent that, in the written opinion (at the substantial authority level) of (i) the Company’s
independent certified public accountants or executive compensation advisory services firm that focuses on matters relating to “golden parachute” excise taxes, in either case, appointed by the Board of Directors prior to any change in
ownership (as defined under Section 280G(b)(2) of the Code), or (ii) tax counsel selected by such accountants or executive compensation advisory services firm (the “Accountants”), in each case, such Company Payments (in whole or
in part) either do not constitute “parachute payments,” represent reasonable compensation for services actually rendered within the meaning of Section 280G(b)(4) of the Code in excess of the “base amount” or are otherwise
not subject to the Excise Tax, and (ii) the value of any non-cash benefits or any deferred payment or benefit shall be determined by the Accountants in accordance with the principles of Section 280G
of the Code. 
 (g)    For purposes of determining whether clause (A) or clause (B) of
Section 5.4(e) applies to the amount of the Company Payments, Bergman’s actual marginal rate of federal income taxation in the calendar year in which the Company Payments are to paid shall be used and the actual marginal rate of taxation
in the state and locality of Bergman’s residence for the calendar year in which the Company Payments are to be made shall be used, net of the maximum reduction in federal income taxes which could be obtained from deduction of such state and
local taxes if paid in such year, after taking into account the limitation on the deductibility of itemized deductions, including such state and local taxes under Section 68 of the Code. The determinations under Sections 5.4(e) and
(g) shall be made by the Accountants and be binding on the Company and Bergman absent manifest error. All costs of the Accountants shall be borne by the Company. 

5.5    OFFICE SUPPORT. If Bergman’s employment hereunder is terminated by the Company without Cause (as defined in
Section 4.3), by the Company choosing not to extend the Employment Period, upon Bergman’s Disability, by Bergman for Good Reason pursuant to 

  
 12 

 
Section 4.1(c)(i), or by Bergman voluntarily pursuant to Section 4.1(c)(ii), prior to the occurrence of a Change in Control, then the Company (i) shall provide Bergman, at the
Company’s cost, an office comparable to that used by him prior to his termination and related office support (including making available the services of one executive assistant) until the last day of the second calendar year following the
calendar year in which Bergman’s date of termination occurs and (ii) shall pay on the second anniversary of Bergman’s date of termination a lump sum in cash equal to the value of the office and related office support specified above
(including the costs of one executive assistant) for the period from the last day of the second calendar year following the calendar year on which date of termination occurs until the third anniversary of his date of termination. If Bergman’s
employment hereunder has been terminated by the Company choosing not to extend the Employment Period, upon Bergman’s Disability, by Bergman for Good Reason pursuant to Section 4.l(c)(i), or by Bergman voluntarily pursuant to
Section 4.1(c)(ii), on or after the occurrence of a Change in Control, the Company (i) shall provide Bergman such office and related office support (including making available the services of one executive assistant) until the last day of
the second calendar year following the calendar year in which Bergman’s date of termination occurs and (ii) shall pay on the second anniversary of Bergman’s date of termination a lump sum in cash equal to the value of the office and
related office support specified above (including the costs of one executive assistant) for the period from the last day of the second calendar year following the calendar year on which date of termination occurs until the fourth anniversary of his
date of termination. The provision of benefits under this Section 5.5 following Bergman’s termination of employment shall be subject to Section 5.7 hereof. 

5.6    VESTING OF OPTIONS, ETC. Notwithstanding anything to the contrary in any other agreement between the Company and
Bergman but subject to Section 5.7 hereof, in the event that Bergman’s employment is terminated (i) by the Company without Cause, by Bergman for Good Reason, due to Bergman’s Retirement, or if the Company chooses not to extend or
not to continue to extend the Employment Period, in each case within two years following a “Change in Control” as such term is defined in Section 4.1, or (ii) by the Company without Cause (x) within 90 days prior to the
occurrence of a Change in Control, or (y) after the first public announcement of the pendency of a Change in Control (but on or prior to a Change in Control), then in each case, any and all options held by Bergman (or his assignees, if
assignment is permissible) to purchase Company capital stock, to the extent not theretofore vested, shall be fully vested and immediately exercisable on the later of the Change in Control or the date of termination, any and all restricted stock
units previously issued to Bergman, to the extent not theretofore vested, shall be fully vested on the later of the Change in Control or the date of termination and, with respect to any and all shares of stock theretofore issued to Bergman bearing
restrictions on transfer imposed by the Company (collectively, the “Restricted Shares”), such restrictions shall thereupon lapse on the later of the Change in Control or the date of termination, provided that, with respect to any
and all restricted stock units and Restricted Shares subject to performance goals that are unvested or subject to restrictions on transfer, as applicable, as of the date of the Change in Control, such restricted stock units shall become vested and
transfer restrictions applicable to such Restricted Shares shall lapse, in each case, on the later of the Change in Control or the date of termination, at target level of performance without regard to achievement of any applicable performance
goals. For purposes of this Agreement, Bergman shall qualify for “Retirement” only if Bergman and the Company mutually agree in good faith to Bergman’s Retirement and Bergman’s Retirement date. 

  
 13 

 5.7    RELEASE REQUIREMENT. In the event Bergman’s employment is
terminated and the Company is obligated to make payments and/or provide benefits to Bergman pursuant to Sections 3.1, 3.3, 5.1, 5.2, 5.3, 5.4, 5.5, and/or 5.6 hereof, other than payments pursuant to Sections 5.1(a), (d), and (e)hereof, it shall be a
condition to such payments that, within 30 days following the date of termination, Bergman (or, in the event of Bergman’s death, Bergman’s estate or designated beneficiaries, as the case may be) enter into a general release of claims in
the form attached hereto as Exhibit B as reasonably revised by the Company to comply with applicable law changes or interpretations or as otherwise necessary to assure enforceability or tax effectiveness; provided, that if any revisions are
made to Exhibit B, such revised Exhibit B is delivered to Bergman within five (5) days following the date of termination. 
  

	 	6.	 CONFIDENTIAL INFORMATION, NON-COMPETITION, ETC. 

(a)    (i)    Both during and after the Employment Period, Bergman shall hold in a
fiduciary capacity for the benefit of the Company and shall not, without the prior written consent of the Company, communicate or divulge (other than in the regular course of the Company’s business), to anyone other than the Company, its
subsidiaries and those designated by it, any confidential or proprietary information, knowledge or data relating to the Company or any of its subsidiaries, or to any of their respective businesses, obtained by Bergman before or during the Employment
Period except to the extent (A) disclosure is made during the Employment Period by Bergman in the course of his duties hereunder and Bergman reasonably determines in good faith that it is in the best interest of the Company to do so,
(B) Bergman is compelled pursuant to an order of a court or other body having jurisdiction over such matter to do so (in which case, to the extent legally permitted, the Company shall be given prompt written notice of such intention to divulge
not less than five days prior to such disclosure or such shorter period as the circumstances may reasonably require) or (C) such information, knowledge or data is or becomes public knowledge or is or becomes generally known within the
Company’s industry other than through improper disclosure by Bergman. Notwithstanding the foregoing, in accordance with 18 U.S.C. § 1833(b), nothing in this Agreement is intended to interfere with or discourage the Bergman’s good
faith disclosure of a trade secret or other confidential information to any governmental entity related to a suspected violation of law. Furthermore, notwithstanding anything to the contrary in this Agreement, the federal Defend Trade Secrets Act of
2016 (the “DTSA”) provides that Bergman cannot be held criminally or civilly liable under any federal or state trade secret law if Bergman discloses a trade secret or other confidential information (i) in confidence to (x) any
federal, state, or local government official, either directly or indirectly, or (y) an attorney, and solely for the purpose of reporting or investigating a suspected violation of the law or (ii) in a complaint or other document filed in a
lawsuit or other proceeding, if such filing is made under seal. The DTSA further provides that an individual who files a lawsuit for retaliation by an employer for reporting a suspected violation of law may disclose the trade secret to the attorney
of the individual and use the trade secret information in the court proceeding, if the individual (i) files any document containing the trade secret under seal and (ii) does not disclose the trade secret, except pursuant to court order.
Bergman may also disclose in good faith confidential information solely to the minimum extent directly related to and reasonably necessary in connection with any litigation between Bergman and the Company or any of its affiliates, provided that
Bergman shall take all actions necessary to ensure that any such disclosure shall be made under seal. 

  
 14 

 (ii)    Bergman acknowledges and agrees that the whole
interest in any invention, improvement, confidential information, copyright, design, plan, drawing or data, including all worldwide rights to copyrights or any other intellectual property rights (collectively, the “Rights”) arising out of
or resulting from Bergman’s performance of his duties during the Employment Period shall be the sole and exclusive property of the Company. Bergman undertakes (at the expense of the Company) to execute any document or do any reasonably
necessary act to enable the Company to obtain or to assist the Company in obtaining any Rights. Bergman hereby irrevocably appoints the Company to be his
attorney-in-fact to execute in his name and on his behalf any instrument required and take any actions reasonably necessary for the purpose of giving to the Company the
full benefit of the provisions of this subsection; provided, however, that the Company shall notify Bergman prior to executing any such instruments or taking any such actions. 

(b)    Bergman will not (other than on behalf of the Company) directly or indirectly, during the Employment
Period and thereafter until the end of the “Restricted Period,” as an individual proprietor, partner, stockholder, officer, employee, director, joint venturer, investor, lender, or in any other capacity whatsoever (other than as the holder
of not more than one percent (1%) of the total outstanding stock of a publicly held company other than Schein Pharmaceutical, Inc., or as a passive investor of not more than one percent (1%) of any
non-publicly held company through hedge funds, private equity funds, mutual funds or similar investment vehicles), (x) engage in any activity competitive with the business of the Company or any of its
affiliates, (y) recruit, solicit or induce (or attempt to recruit, solicit or induce) any employee of, or consultant to, the Company or any of its affiliates (other than his personal administrative assistant) to terminate their employment with,
or otherwise cease their relationship with, the Company or any of its affiliates, or (z) divert (or attempt to divert) any person or entity from doing business with the Company or any of its affiliates or induce (or attempt to induce) any
person or entity from ceasing to be a customer or other business partner of the Company or any of its affiliates. The “Restricted Period” shall end (A) one year after termination of employment if termination is due to a termination by
the Company without Cause or by a Company non-renewal under Section 5.3, by Bergman for Good Reason pursuant to Section 4.1(c)(i), or because of Bergman’s Disability (such one-year period may be extended for an additional year at the Company’s option; provided, however, that upon making such election which shall be made no less than 180 days prior to the expiration
of such one-year period, the Company shall pay Bergman on the day immediately following the six-month anniversary of his date of termination, a lump sum cash amount
equal to 100% of his Base Salary (as of the date of such termination)), or (B) upon the later of the second anniversary of the expiration of the Employment Period and the Employment Expiration Date, if such termination is due to a termination
by the Company for Cause or by Bergman voluntarily pursuant to Section 4.1(c)(ii). 

  
 15 

 (c)    If any restriction set forth in Section 6(b)
is found by any court of competent jurisdiction or arbitrator to be unenforceable because it extends for too long a period of time or over too great a range of activities or in too broad a geographic area, it shall be interpreted to extend only over
the maximum period of time, range of activities or geographic area as to which it may be enforceable. 

(d)    The restrictions contained in Sections 6(a) and (b) are necessary for the protection of the
business and goodwill of the Company and are considered by Bergman to be reasonable to such purpose. Bergman acknowledges and agrees that money damages would not adequately compensate the Company for any breach of Section 6(a) or 6(b) and will
cause the Company substantial and irreparable damage and therefore, in the event of any such breach, in addition to such other remedies which may be available, the Company shall have the right to seek specific performance and injunctive relief. 

 

	 	7.	 NO MITIGATION; NO SET-OFF 

The Company agrees that if Bergman’s employment with the Company is terminated prior to the Employment Expiration Date for any reason
whatsoever, Bergman is not required to seek other employment or to attempt in any way to reduce any amounts payable to Bergman by the Company pursuant to this Agreement. Further, the amount of any payment provided for in this Agreement shall not be
reduced by any compensation earned by Bergman as the result of employment by another employer or otherwise; and the amount of any benefit provided for in this Agreement shall not be reduced by any benefit provided to Bergman as the result of
employment by another employer or otherwise (other than the health and medical benefits to the extent provided for in Section 3.1, which may be reduced solely by any health and medical benefits that Bergman and his spouse are eligible to
receive under any health and medical benefit plans of any subsequent employer). The Company’s obligations to make the payments provided for in this Agreement and otherwise to perform its obligations hereunder shall not be affected by any set-off, counterclaim, recoupment, or other similar right which the Company may have against Bergman. 
  

	 	8.	 LEGAL FEES 

If the Company fails to timely make any payment due hereunder and Bergman seeks to collect such amounts or negotiate a settlement, and either
(i) reaches a settlement for any part or all of the payments provided for hereunder, or (ii) successfully enforces the terms of this Agreement, through litigation or arbitration, by or through a lawyer, the Company shall advance all
reasonable costs of such collection or enforcement, including reasonable legal fees and disbursements and other fees and expenses which Bergman may incur, promptly after submission of documentation reasonably acceptable to the Company in respect of
such costs and expenses. All amounts paid by the Company shall promptly be refunded to the Company if and when a court of competent jurisdiction finds that the Company is entitled to have such sums refunded or if a settlement is reached which is
insubstantial compared to the damages that were requested. The Company shall pay or reimburse Bergman for all reasonable legal fees incurred by him in connection with the negotiation and execution of this Agreement; provided that such payment or
reimbursement shall be paid promptly and in no event later than the later of (i) the 15th day of the third month following the end of the calendar year in which the legal fees are incurred or
(ii) the 15th day of the third month following the end of the fiscal year in which the legal fees are incurred. 

  
 16 

	 	9.	 SUCCESSORS; BINDING AGREEMENT 

(a)    Unless otherwise resulting by operation of law, the Company shall require any successor (whether
direct or indirect, by purchase, merger, consolidation or otherwise) to all or substantially all of the business or assets of the Company to expressly assume and agree in writing to perform this Agreement in the same manner, and to the same extent
that the Company would be required to perform it if no such transaction had taken place. As used in this Agreement, “Company” shall mean the Company as hereinbefore defined and any successor to its business or assets as aforesaid which
assumes and agrees to perform this Agreement by operation of law, or otherwise. 
 (b)    The Company may
not assign this Agreement except in connection with, and to the acquiror of, all or substantially all of the business or assets of the Company, provided such acquiror expressly assumes and agrees in writing to perform this Agreement as provided in
Section 9(a). 
 (c)    This Agreement shall inure to the benefit of and be enforceable by Bergman
and his personal or legal representatives, executors, administrators, successors, heirs, distributees, devisees and legatees; provided, however, that this Agreement may not be assigned by Bergman. 

(d)    The parties agree that, in addition to the persons or entities referred to in Section 9(c)
above, who shall be third party beneficiaries of the entire Agreement in the event of Bergman’s death or Disability, Bergman’s spouse is a third party beneficiary of Section 3.1 and, to the extent that the events described therein
would cause her to be entitled to the benefit of rights granted to her under Section 3.1, or any provision of Section 5, she shall have the right to enforce such provisions as fully as if she were a party to this Agreement. 

 

	 	10.	 MISCELLANEOUS 

(a)    Any notices or other communications required or permitted to be given hereunder shall be in writing
and shall be deemed to have been duly made, given or received when hand-delivered, one business day after being transmitted by telecopier (confirmed by mail) or sent by overnight courier against receipt, or five days after being mailed by registered
or certified mail, postage prepaid, return receipt requested, to the party to whom such communication is given at the address set forth below, which address may be changed by notice given in accordance with this Section: 

If to the Company: 

Henry Schein, Inc. 
 135 Duryea
Road 
 Melville, New York 11747 

Attention: Corporate Secretary 

  
 17 

 If to Bergman: 

Stanley M. Bergman 
 c/o Henry
Schein, Inc. 
 135 Duryea Road 

Melville, New York 11747 

(b)    If any provision of this Agreement shall be held by court of competent jurisdiction to be illegal,
invalid or unenforceable, including, without limitation, under any provision of the Sarbanes-Oxley Act of 2002, as amended from time to time, such provision shall be construed and enforced as if it had been more narrowly drawn so as not to be
illegal, invalid or unenforceable and such illegality, invalidity or unenforceability shall have no effect upon and shall not impair the enforceability of any other provision of this Agreement. 

(c)    No provision of this Agreement may be modified, waived or discharged except by a waiver,
modification or discharge in writing signed by Bergman and such officer as may be designated by the Board of Directors. No waiver by either party hereto at any time of any breach by the other party hereto of, or in compliance with, any condition or
provision of this Agreement to be performed by such other party shall be deemed a waiver of similar or dissimilar provisions or conditions at the time or at any prior or subsequent time. No agreements or representations, oral or otherwise, express
or implied, with respect to the subject matter have been made by either party which are not expressly set forth in this Agreement. 

(d)    This Agreement represents the entire agreement of the parties and shall supersede any and all
previous contracts, arrangements or understandings between the Company and Bergman with respect to the subject matter, including, without limitation, as of the Effective Date, the Prior Agreement. 

(e)    This Agreement shall be construed, interpreted, and governed in accordance with the laws of the
State of New York, without reference to rules relating to conflicts of law. 
 (f)    The section
headings herein are for the purpose of convenience only and are not intended to define or limit the contents of any section. 

(g)    The parties may sign this Agreement in counterparts, all of which shall be considered one and the
same instrument. 
 (h)    It is intended that the provisions of this Agreement comply with, or be exempt
from, Section 409A of the Code and the regulations and guidance promulgated thereunder (collectively “Code Section 409A”), and all provisions of this Agreement (or of any award of compensation, including equity compensation or
benefits) shall be construed in a manner consistent with the requirements for avoiding taxes or penalties under Code Section 409A. Notwithstanding the foregoing, the Company does not 

  
 18 

 
guarantee any particular tax treatment and the Company shall have no liability with regard to any failure to comply with Code Section 409A. In the event the Company and Bergman agree that
the payment of compensation or benefits under this Agreement would be in violation of Code Section 409A, the Company and Bergman shall in good faith cooperate to attempt to modify any such payments in order to comply with Code Section 409A
while preserving the intended economic benefits in all material respects. In no event whatsoever shall the Company be liable for any additional tax, interest or penalty that may be imposed on Bergman pursuant to Code Section 409A or any damages
for failing to comply with Code Section 409A. Notwithstanding anything contained in this Agreement to the contrary, each and every payment made under this Agreement shall be treated as a separate and distinct payment and not as a series of
payments. In no event shall Bergman designate the tax year of the commencement of any payments or benefits hereunder and the Company shall determine the actual commencement date of payment of any payments or benefits hereunder. Notwithstanding the
foregoing or anything else contained in this Agreement to the contrary, if Bergman is a “specified employee” (determined in accordance with Code Section 409A and Treasury Regulation
Section 1.409A-3(i)(2)) as of the termination date, and if any payment, benefit or entitlement provided for in this Agreement both (i) constitutes a “deferral of compensation” within the
meaning of Code Section 409A and (ii) cannot be paid or provided in a manner otherwise provided herein or otherwise without subjecting Bergman to additional tax, interest and/or penalties under Code Section 409A, then any such
payment, benefit or entitlement that is payable during the first 6 months following the date of Bergman’s separation from service shall be paid or provided to Bergman in a lump sum cash payment to be made on the earlier of
(x) Bergman’s death or (y) the first business day of the seventh calendar month immediately following the month in which the separation from service occurs. A termination of employment shall not be deemed to have occurred for purposes
of any provision of this Agreement providing for the payment of any amounts or benefits, which are subject to Code Section 409A, upon or following a termination of employment unless such termination is also a “separation from service”
within the meaning of Code Section 409A (and the guidance issued thereunder) and, for purposes of any such provision of this Agreement, references to a “resignation,” “termination,” “termination of employment,”
“retirement” or like terms shall mean separation from service. 
 (i)    Notwithstanding
anything herein to the contrary, Bergman agrees and acknowledges that his cash and non-cash incentive compensation (whether provided under this Agreement or otherwise) shall be subject to the terms and
conditions of the Company’s Incentive Compensation Recoupment Policy approved by the Board in March 2016. Notwithstanding the foregoing, Bergman agrees that incentive compensation, as defined under of the Dodd-Frank Wall Street Reform and
Consumer Protection Act of 2010 and such regulations as are promulgated thereunder from time to time (“Dodd-Frank”), payable to Bergman under the Company’s bonus plans, this Agreement or any other plan, arrangement or program
established or maintained by the Company shall be subject to any clawback policy adopted or implemented by the Company in respect of Dodd-Frank, or in respect of any other applicable law or regulation. In the event of a Change in Control, no
clawback policy of the Company shall continue to apply to Bergman’s cash and non-cash incentive compensation on and after a Change in Control, 

  
 19 

 
other than (i) any clawback policy mandated by Dodd-Frank or other applicable law or (ii) any clawback policy that recoups incentive compensation due to any act or omission by Bergman
that constitutes or could reasonably be expected to constitute Cause (as defined under this Agreement) or any act or omission that involves Bergman’s gross or willful misconduct that gives rise to a material restatement of the Company’s
financial statements. 
 IN WITNESS WHEREOF, the parties hereto have set their hands as of the day and year first above written. 

 

			
	HENRY SCHEIN, INC.
		
	By:	 	 /s/ Gerald A. Benjamin

		 	Authorized Officer
		
		 	Gerald A. Benjamin
		 	Executive Vice President, Chief Administrative Officer
		
	By:	 	 /s/ Stanley M. Bergman

		 	STANLEY M. BERGMAN

  
 20 

 Exhibit A-1 

TIME-BASED RSU AWARD AGREEMENT 

 EXHIBIT A-1 

RESTRICTED STOCK UNIT AGREEMENT 

PURSUANT TO THE 
 HENRY
SCHEIN, INC. 2013 STOCK INCENTIVE PLAN 
 (AS AMENDED AND RESTATED EFFECTIVE AS OF MAY 14, 2013) 

THIS AGREEMENT (the “Agreement”) made as of             , 20191 (the “Grant Date”), by and between Henry Schein, Inc. (the “Company”) and Stanley M. Bergman (the “Participant”). 

W I T N E S S E T H: 

WHEREAS, the Company has adopted the Henry Schein, Inc. 2013 Stock Incentive Plan (As Amended and Restated Effective as of May 14,
2013), as amended from time to time, a copy of which is on file with the Company’s Corporate Human Resources Department and is available for Participant to review upon request at reasonable intervals as determined by the Company (the
“Plan”), which is administered by a Committee appointed by the Company’s Board of Directors (the “Committee”); and 

WHEREAS, pursuant to Section 9 of the Plan, the Committee may grant Restricted Stock Units to Key Employees under the Plan; and

 WHEREAS, the Participant is a Key Employee of the Company. 

NOW, THEREFORE, for and in consideration of the mutual promises herein contained, and for other good and valuable consideration, the
receipt and sufficiency of which are hereby acknowledged, the parties agree as follows: 
  

	1.	 Grant of Restricted Stock Units.  

(a)    Subject to the restrictions and other conditions set forth herein, the Committee has authorized this grant of
[            ] Restricted Stock Units to the Participant on the Grant Date. 
  

	2.	 Vesting and Payment. 

(a)    Except as otherwise provided in this Section 2, the Restricted Stock Units awarded under this Agreement shall
not vest until December 31, 2022 (the “Vesting Date”). Notwithstanding anything herein to the contrary, but except as set forth in Sections 2(b), 2(c), 2(d) and 2(e), the Participant must be continuously employed by the Company or a
Subsidiary from the Grant Date through the Vesting Date. 
 (b)    Retirement. In the event of the
Participant’s Retirement (as defined in the Amended and Restated Employment Agreement dated as of August 8, 2019, between the Company and the Participant (the “Employment Agreement”)) prior to the Vesting Date, a pro-rata portion of the Restricted Stock Units shall vest, based on Participant’s service with the Company through the date of Retirement (such date referred to herein as a
“Pro-rata Vesting Date”). The remaining Restricted Stock Units (i.e., any Restricted Stock Units that are not vested on the Pro-Rata Vesting Date) shall be
deemed vested on the Vesting Date, subject to the Participant’s compliance with the restrictive covenants set forth in Section 6 of the Employment Agreement through the Vesting Date. If the Participant breaches such restrictive covenants
prior to the Vesting Date, the remaining Restricted Stock Units shall be forfeited. 
  

	1 	 To be granted automatically, without further action of the Compensation Committee, on the first business day
immediately following the twentieth (20th) trading day after August 8, 2019, subject in all cases to the Participant’s continued employment through the actual grant date of the RSU Award.

  
 1 

 (c)    Death or Disability. In the event of the
Participant’s death (prior to a Termination of Employment or following Retirement as described in Section 2(b) or a Termination of Employment as described in Section 2(e)) or Disability (prior to a Termination of Employment), the
Restricted Stock Units shall become fully vested on such death or Disability. For purposes of this Agreement, “Disability” means that the Participant is disabled within the meaning of Section 409A(a)(2)(C)(i) or (ii) of the Code.

 (d)    Change of Control. In the event of the Participant’s Termination of Employment for
any reason, other than for Cause (as defined in the Employment Agreement), within the two year period following a Change of Control, the Restricted Stock Units shall become fully vested upon the Participant’s Termination of Employment (the
“Change of Control Vesting Date”). For purposes of this Agreement, a “Change of Control” shall mean the occurrence of a Section 409A Change of Control (as defined in Section 3). In the event of a Change of Control
occurring on or after the Participant’s Retirement or Termination of Employment without Cause or for Good Reason, and on or before December 31, 2022, the remaining Restricted Stock Units (i.e., any Restricted Stock Units that are not
vested on the applicable Pro Rata Vesting Date) shall become fully vested upon the Change of Control. 

(e)    Termination of Employment without Cause or for Good Reason. In the event the
Participant’s employment is terminated by the Company without Cause or by the Participant for Good Reason (as such terms are defined on the Employment Agreement), a pro-rata portion of the Restricted
Stock Units shall vest, based on Participant’s service with the Company through the date of Termination of Employment (such date referred to herein as a “Pro-rata Vesting Date”). The remaining
Restricted Stock Units (i.e., any Restricted Stock Units that are not vested on the Pro-Rata Vesting Date) shall be deemed vested on the Vesting Date notwithstanding the Participant’s Termination of
Employment prior to such date. 
 (f)    Payment. The Participant shall be entitled to receive one
share of Common Stock with respect to one vested Restricted Stock Unit. The Participant shall be paid one share of Common Stock with respect to each vested Restricted Stock Unit within thirty (30) days of the Vesting Date; except that: 

(i)    in the event of the Participant’s death, the Participant’s estate shall be paid within thirty
(30) days of the Participant’s death; 
 (ii)    in the event of the Participant’s Disability, the
Participant shall be paid within thirty (30) days of Disability; 
 (iii)    in the event of a Change of Control
Vesting Date, the Participant shall be paid within thirty (30) days of the Change of Control Vesting Date, subject to a six month delay following the Participant’s Termination of Employment to the extent required by Section 409A of
the Code; 
 (iv)    in the event of the Participant’s Retirement, the Participant shall be paid (A) with
respect to the pro-rata portion of Restricted Stock Units vested on his Retirement, within thirty (30) days of the Pro-rata Vesting Date, subject to a six month
delay following the Participant’s Retirement to the extent required by Section 409A of the Code, and (B) with respect to the remaining Restricted Stock Units, subject to compliance with Section 2(b), within thirty (30) days
of the earlier of the Vesting Date or a Change of Control; 

  
 2 

 (v)    in the event of the Participant’s Termination of Employment
without Cause or Termination of Employment for Good Reason whether occurring on, before or after a Change of Control, the Participant shall be paid (A) with respect to the pro-rata portion of Restricted
Stock Units vested on his date of Termination of Employment, with thirty (30) days of the Pro-rata Vesting Date, subject to a six month delay following the Participant’s Termination of Employment to
the extent required by Section 409A of the Code, and (B) with respect to the remaining Restricted Stock Units, within thirty (30) days of the earlier of the Vesting Date or a Change of Control; 

(vi)    in the event of non-renewal of the Employment Agreement, the Participant
shall be paid within thirty (30) days of the Vesting Date. 
 3.    Change of Control Definition. For purposes of
this Agreement, a “Section 409A Change of Control” shall have the meaning set forth in Appendix A, attached hereto; provided, that, no event shall constitute a “Change of Control” for purposes of this Agreement unless such
event also qualifies as a “change in control event” for purposes of Treasury Regulation § 1.409A-3(i)(5). 

4.    Termination. Except as otherwise provided in Sections 2(b), 2(c), 2(d) and 2(e), all unvested Restricted Stock Units
will be forfeited on the Participant’s Termination of Employment. 
 5.    Dividend Equivalents. Cash dividends on
Shares shall be credited to a dividend book entry account on behalf of the Participant with respect to each Restricted Stock Unit granted to the Participant, provided that such cash dividends shall not be deemed to be reinvested in Shares and will
be held uninvested and without interest. The Participant’s right to receive any such cash dividends shall vest if and when the related Restricted Stock Unit vests, and such cash dividends shall be paid in cash to the Participant if and when the
related Restricted Stock Unit is paid to the Participant. Stock dividends on Shares shall be credited to a dividend book entry account on behalf of the Participant with respect to each Restricted Stock Unit granted to the Participant. The
Participant’s right to receive any such stock dividends shall vest if and when the related Restricted Stock Unit vests, and such stock dividends shall be paid in stock to the Participant if and when the related Restricted Stock Unit is paid to
the Participant. 
 6.    Rights as a Stockholder. The Participant shall have no rights as a stockholder with respect to
any Shares covered by any Restricted Stock Unit unless and until the Participant has become the holder of record of the Shares, and no adjustments shall be made for dividends in cash or other property, distributions or other rights in respect of any
such Shares, except as otherwise specifically provided for in this Agreement or the Plan. 
 7.    Provisions of Plan
Control. This Agreement is subject to all the terms, conditions and provisions of the Plan, including, without limitation, the amendment provisions thereof, and to such rules, regulations and interpretations relating to the Plan as may be
adopted by the Committee and as may be in effect from time to time. The Plan is incorporated herein by reference. Capitalized terms in this Agreement that are not otherwise defined shall have the same meaning as set forth in the Plan. If and to the
extent that this Agreement conflicts or is inconsistent with the terms, conditions and provisions of the Plan, the Plan shall control, and this Agreement shall be deemed to be modified accordingly. This Agreement contains the entire understanding of
the parties with respect to the subject matter hereof and supersedes any prior agreements between the Company and the Participant with respect to the subject matter hereof. 

8.    Amendment. The Board or the Committee may amend, suspend or terminate this Agreement subject to the terms of the Plan.
Except as otherwise provided in the Plan, no modification or waiver of any of the provisions of this Agreement shall be effective unless in writing and signed by the party against whom it is sought to be enforced. 

9.    Notices. Any notice or communication given hereunder shall be in writing and shall be deemed to have been duly given
when delivered in person, or by regular United States mail, first class and prepaid, to the appropriate party at the address set forth below (or such other address as the party shall from time to time specify): 

If to the Company, to: 
 Henry
Schein, Inc. 
 135 Duryea Road 

Melville, New York 11747 

Attention: General Counsel 
 If to
the Participant, to the address on file with the Company. 

  
 3 

 10.    No Obligation to Continue Employment. This Agreement is not an
agreement of employment. This Agreement does not guarantee that the Company or its Subsidiaries will employ or retain, or to continue to, employ or retain the Participant during the entire, or any portion of the, term of this Agreement, including
but not limited to any period during which the Restricted Stock Unit is outstanding, nor does it modify in any respect the Company or its Subsidiary’s right to terminate the Participant’s employment or modify the Participant’s
compensation, except to the extent provided in the Participant’s Employment Agreement. 
 11.    Legend. The Company
may at any time place legends referencing any applicable federal, state or foreign securities law restrictions on all certificates representing Shares issued pursuant to this Agreement. The Participant shall, at the request of the Company, promptly
present to the Company any and all certificates representing Shares acquired pursuant to this Agreement in the possession of the Participant in order to carry out the provisions of this Section 11. 

12.    Securities Representations. The grant of the Restricted Stock Units and issuance of Shares upon vesting of the
Restricted Stock Units shall be subject to, and in compliance with, all applicable requirements of federal, state or foreign securities law. No Shares may be issued hereunder if the issuance of such Shares would constitute a violation of any
applicable federal, state or foreign securities laws or other law or regulations or the requirements of any stock exchange or market system upon which the Shares may then be listed. As a condition to the settlement of the Restricted Stock Units, the
Company may require the Participant to satisfy any qualifications that may be necessary or appropriate to evidence compliance with any applicable law or regulation. 

The Shares are being issued to the Participant and this Agreement is being made by the Company in reliance upon the following express
representations and warranties of the Participant. The Participant acknowledges, represents and warrants that: 

(a)    He or she has been advised that he or she may be an “affiliate” within the meaning of Rule 144 under the
Securities Act of 1933, as amended (the “Act”) and in this connection the Company is relying in part on his or her representations set forth in this section. 

(b)    If he or she is deemed an affiliate within the meaning of Rule 144 of the Act, the Shares must be held indefinitely
unless an exemption from any applicable resale restrictions is available or the Company files an additional registration statement (or a “re-offer prospectus”) with regard to such Shares and the
Company is under no obligation to register the Shares (or to file a “re-offer prospectus”). 

(c)    If he or she is deemed an affiliate within the meaning of Rule 144 of the Act, he or she understands that the
exemption from registration under Rule 144 will not be available unless (i) a public trading market then exists for the Common Stock of the Company, (ii) adequate information concerning the Company is then available to the public, and
(iii) other terms and conditions of Rule 144 or any exemption therefrom are complied with; and that any sale of the Shares may be made only in limited amounts in accordance with such terms and conditions. 

13.    Transfer of Personal Data. The Participant authorizes, agrees and unambiguously consents to the transmission by the
Company of any personal data information related to the Restricted Stock Units awarded under this Agreement, for legitimate business purposes (including, without limitation, the administration of the Plan) out of the Participant’s home country
and including to countries with less data protection than the data protection provided by the Participant’s home country. This authorization/consent is freely given by the Participant. 

14.    Section 409A. Any provisions in this Agreement providing for the payment of “nonqualified deferred
compensation” (as defined in Section 409A of the Code and the Treasury regulations thereunder) to the Participant are intended to comply with the requirements of Section 409A of the Code, and this Agreement shall be interpreted in
accordance therewith. Neither party individually or in combination may accelerate or defer the timing of the payment of any such nonqualified deferred compensation, except in compliance with Section 409A of the Code and

  
 4 

 
this Agreement, and no amount shall be paid prior to the earliest date on which it is permitted to be paid under Section 409A of the Code and this Agreement. In no event whatsoever shall the
Company be liable for any additional tax, interest or penalty that may be imposed on the Participant as a result of Section 409A of the Code or any damages for failing to comply with Section 409A of the Code. Whenever a payment under this
Agreement may be paid within a specified period, the actual date of payment within the specified period shall be within the Company’s sole discretion. 

15.    Miscellaneous. This Agreement shall inure to the benefit of and be binding upon the parties hereto and their
respective heirs, legal representatives, successors and assigns. 
 (a)    This Agreement shall be governed and
construed in accordance with the laws of New York (regardless of the law that might otherwise govern under applicable New York principles of conflict of laws). 

(b)    This Agreement may be executed in one or more counterparts, all of which taken together shall constitute one
contract. 
 (c)    The failure of any party hereto at any time to require performance by another party of any provision
of this Agreement shall not affect the right of such party to require performance of that provision, and any waiver by any party of any breach of any provision of this Agreement shall not be construed as a waiver of any continuing or succeeding
breach of such provision, a waiver of the provision itself, or a waiver of any right under this Agreement. 

  
 5 

 IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the day and
year first set forth above. 
  

			
	HENRY SCHEIN, INC.
		
	          	 	Michael S. Ettinger
		 	Senior Vice President, Corporate & Legal Affairs and Chief of Staff, Secretary
	
	Stanley M. Bergman
	
	  

  
 6 

 Appendix A 

This is Appendix A to the Restricted Stock Unit Agreement Pursuant to the Henry Schein, Inc. 2013 Stock Incentive Plan (As Amended and Restated Effective as
of May 14, 2013) (the “RSU Agreement”). For purposes of Section 3 of the RSU Agreement, a “Section 409A Change of Control” shall be deemed to have occurred upon: 

(i) an acquisition by any Person of beneficial ownership (within the meaning of Rule 13d-3 promulgated under the Act)
of (A) 50% or more of the then outstanding Shares or (B) 33% or more of the total combined voting power of the then outstanding voting securities of HSI entitled to vote generally in the election of directors (the “Outstanding HSI Voting
Securities”); excluding, however, the following: (w) any acquisition directly from the Company, other than an acquisition by virtue of the exercise of a conversion privilege unless the security being so converted was itself acquired
directly from the Company, (x) any acquisition by the Company, (y) any acquisition by an employee benefit plan (or related trust) sponsored or maintained by the Company or (z) any acquisition by any corporation pursuant to a
reorganization, merger, consolidation or similar corporate transaction (in each case, a “Corporate Transaction”), if, pursuant to such Corporate Transaction, the conditions described in clauses (A), (B) and (C) of paragraph
(iii) below are satisfied; or 
 (ii) within any 12-month period beginning on or after the date of the RSU
Agreement, the individuals who constitute the Board immediately before the beginning of such period (the Board as of the date hereof shall be hereinafter referred to as the “Incumbent Board”) cease for any reason to constitute at least a
majority of the Board; provided that for purposes of this Subsection any individual who becomes a member of the Board subsequent to the date hereof whose election, or nomination for election by HSI’s stockholders, was approved by a vote of at
least a majority of those individuals who are members of the Board and who are also members of the Incumbent Board (or deemed to be such pursuant to this proviso) shall be considered as though such individual were a member of the Incumbent Board;
but, provided further, that any such individual whose initial assumption of office occurs as a result of either an actual or threatened election contest (as such terms are used in Rule 14a-11 of Regulation 14A
promulgated under the Act) or other actual or threatened solicitation of proxies or consents by or on behalf of a Person other than the Board shall not be so considered as a member of the Incumbent Board; or 

(iii) the consummation of a Corporate Transaction; excluding, however, such a Corporate Transaction pursuant to which (A) all or substantially all of the
individuals and entities who are the beneficial owners, respectively, of the outstanding Shares and Outstanding HSI Voting Securities immediately prior to such Corporate Transaction will beneficially own, directly or indirectly, more than 60% of,
respectively, the outstanding shares of common stock of the corporation resulting from such Corporate Transaction and the combined voting power of the outstanding voting securities of such corporation entitled to vote generally in the election of
directors, in substantially the same 

  
 7 

 
proportions as their ownership, immediately prior to such Corporate Transaction, of the outstanding Shares and Outstanding HSI Voting Securities, as the case may be, (B) no Person (other
than the Company, any employee benefit plan (or related trust) of the Company or the corporation resulting from such Corporate Transaction and any Person beneficially owning, immediately prior to such Corporate Transaction, directly or indirectly,
33% or more of the outstanding Shares or Outstanding HSI Voting Securities, as the case may be, will beneficially own, directly or indirectly, 33% or more of, respectively, the outstanding shares of common stock of the corporation resulting from
such Corporate Transaction or the combined voting power of the then outstanding securities of such corporation entitled to vote generally in the election of directors and (C) individuals who were members of the Incumbent Board will constitute
at least a majority of the members of the board of directors of the corporation resulting from such Corporate Transaction; or 
 (iv) the sale or other
disposition of all or substantially all of the assets of the Company; excluding, however, such sale or other disposition to a corporation with respect to which, following such sale or other disposition, (x) more than 60% of, respectively, the
then outstanding shares of common stock of such corporation and the combined voting power of the then outstanding voting securities of such corporation entitled to vote generally in the election of directors will be then beneficially owned, directly
or indirectly, by all or substantially all of the individuals and entities who were the beneficial owners, respectively, of the outstanding Common Stock and Outstanding HSI Voting Securities immediately prior to such sale or other disposition in
substantially the same proportion as their ownership, immediately prior to such sale or other disposition, of the outstanding Common Stock and Outstanding HSI Voting Securities, as the case may be, (y) no Person (other than the Company and any
employee benefit plan (or related trust) of the Company or such corporation and any Person beneficially owning, immediately prior to such sale or other disposition, directly or indirectly, 33% or more of the outstanding Common Stock or Outstanding
HSI Voting Securities, as the case may be) will beneficially own, directly or indirectly, 33% or more of, respectively, the then outstanding shares of common stock of such corporation and the combined voting power of the then outstanding voting
securities of such corporation entitled to vote generally in the election of directors and (z) individuals who were members of the Incumbent Board will constitute at least a majority of the members of the board of directors of such corporation.

 (v) No event set forth herein shall constitute a “Section 409A Change of Control” unless such event also qualifies as a “change in
control event” for purposes of Treasury Regulation § 1.409A-3(i)(5). Accordingly, the definition of “Section 409A Change of Control” set forth herein shall be limited, construed and
interpreted in accordance with Section 409A and the regulations issued thereunder. 

  
 8 

 Exhibit A-2 

PERFORMANCE-BASED RSU AWARD AGREEMENT 

 EXHIBIT A-2 

RESTRICTED STOCK UNIT AGREEMENT 

PURSUANT TO THE 
 HENRY
SCHEIN, INC. 2013 STOCK INCENTIVE PLAN 
 (AS AMENDED AND RESTATED EFFECTIVE AS OF MAY 14, 2013) 

THIS AGREEMENT (the “Agreement”) made as of             , 20191 (the “Grant Date”), by and between Henry Schein, Inc. (the “Company”) and Stanley M. Bergman (the “Participant”). 

W I T N E S S E T H: 

WHEREAS, the Company has adopted the Henry Schein, Inc. 2013 Stock Incentive Plan (As Amended and Restated Effective as of May 14,
2013), as amended from time to time, a copy of which is on file with the Company’s Corporate Human Resources Department and is available for Participant to review upon request at reasonable intervals as determined by the Company (the
“Plan”), which is administered by a Committee appointed by the Company’s Board of Directors (the “Committee”); and 

WHEREAS, pursuant to Section 9 of the Plan, the Committee may grant Restricted Stock Units to Key Employees under the Plan; and

 WHEREAS, the Participant is a Key Employee of the Company. 

NOW, THEREFORE, for and in consideration of the mutual promises herein contained, and for other good and valuable consideration, the
receipt and sufficiency of which are hereby acknowledged, the parties agree as follows: 
  

	1.	 Grant of Restricted Stock Units.  

(a)    Subject to the restrictions and other conditions set forth herein, the Committee has authorized this grant of
[            ] Restricted Stock Units to the Participant on the Grant Date. 
  

	2.	 Vesting and Payment. 

(a)    Except as otherwise provided in this Section 2, the Restricted Stock Units awarded under this Agreement shall
not vest unless and until (i) the Committee determines and certifies that the performance goals determined by the Committee in writing by March 31, 2020 (the “Performance Goals”) and communicated to the Participant have been
satisfied with respect to the three year period beginning on the first day of the fiscal year of the Company commencing after the Grant Date, and (ii) December 31, 2022. The date on which both (i) and (ii) have been attained shall be
the “Vesting Date”. Except as set forth in Sections 2(c) and 2(d), if the Performance Goals are not satisfied in accordance with Section 2(a)(i), the Restricted Stock Units awarded under this Agreement shall be forfeited.
Notwithstanding anything herein to the contrary, but except as set forth in Sections 2(b), 2(c), 2(d) and 2(e), the Participant must be employed by the Company or a Subsidiary at the times the Performance Goals are satisfied and on the Vesting Date.

 (b)    Retirement. In the event of the Participant’s Retirement (as defined in the Amended
and Restated Employment Agreement dated as of August 8, 2019, between the Company and the Participant (the “Employment Agreement”)) prior to the Vesting Date, a pro-rata portion of the
Restricted Stock Units shall vest, subject to achievement of the Performance Goals to the date of Retirement (such date referred to herein as a “Pro-rata Vesting Date”). The remaining Restricted
Stock Units (i.e., any Restricted Stock Units that are not vested on the Pro-Rata Vesting Date) shall continue to vest in accordance with Section 2(a) following the Participant’s Retirement, subject
to the Participant’s compliance with the restrictive covenants set forth in Section 6 of the Employment Agreement through the Vesting Date. If the Participant breaches such restrictive covenants prior to the Vesting Date, the remaining
Restricted Stock Units shall be forfeited.    Further, the remaining Restricted Stock Units shall be forfeited if the Performance Goals described in Section 2(a)(i) are not achieved by December 31, 2022. 

 

	1 	 To be granted automatically, without further action of the Compensation Committee, on the first business day
immediately following the twentieth (20th) trading day after August 8, 2019, subject in all cases to the Participant’s continued employment through the actual grant date of the RSU Award.

  
 1 

 (c)    Death or Disability. In the event of the
Participant’s death (prior to a Termination of Employment or following Retirement as described in Section 2(b) or a Termination of Employment as described in Section 2(e)) or Disability (prior to a Termination of Employment), the
Restricted Stock Units shall become fully vested at target level on such death or Disability, without regard to achievement of the Performance Goals described in Section 2(a)(i). For purposes of this Agreement, “Disability” means that
the Participant is disabled within the meaning of Section 409A(a)(2)(C)(i) or (ii) of the Code. 

(d)    Change of Control. In the event of the Participant’s Termination of Employment for any
reason, other than for Cause (as defined in the Employment Agreement), within the two year period following a Change of Control, the Restricted Stock Units shall become fully vested at target level upon the Participant’s Termination of
Employment (the “Change of Control Vesting Date”), without regard to achievement of the Performance Goals described in Section 2(a)(i). For purposes of this Agreement, a “Change of Control” shall mean the occurrence of a
Section 409A Change of Control (as defined in Section 3). In the event of a Change of Control occurring on or after the Participant’s Retirement or Termination of Employment without Cause or for Good Reason, and on or before
December 31, 2022, the remaining Restricted Stock Units (i.e., any Restricted Stock Units that are not vested on the applicable Pro Rata Vesting Date) shall become fully vested at target level upon the Change of Control, without regard to
achievement of the Performance Goals described in Section 2(a)(i) 
 (e)    Termination of Employment without
Cause or for Good Reason. In the event the Participant’s employment is terminated by the Company without Cause or by the Participant for Good Reason (as such terms are defined on the Employment Agreement), a pro-rata portion of the Restricted Stock Units shall vest, subject to achievement of the Performance Goals to the date of Termination of Employment (such date referred to herein as a
“Pro-rata Vesting Date”). The remaining Restricted Stock Units (i.e., any Restricted Stock Units that are not vested on the Pro-Rata Vesting Date) shall
continue to vest in accordance with Section 2(a) following the Participant’s Termination of Employment. The remaining Restricted Stock Units shall be forfeited if the Performance Goals described in Section 2(a)(i) are not achieved by
December 31, 2022. 
 (f)    Payment. The Participant shall be entitled to receive one share
of Common Stock with respect to one vested Restricted Stock Unit. The Participant shall be paid one share of Common Stock with respect to each vested Restricted Stock Unit within thirty (30) days of the Vesting Date; except that: 

(i)    in the event of the Participant’s death, the Participant’s estate shall be paid within thirty
(30) days of the Participant’s death; 
 (ii)    in the event of the Participant’s Disability, the
Participant shall be paid within thirty (30) days of Disability; 

  
 2 

 (iii)    in the event of a Change of Control Vesting Date, the
Participant shall be paid within thirty (30) days of the Change of Control Vesting Date, subject to a six month delay following the Participant’s Termination of Employment to the extent required by Section 409A of the Code; 

(iv)    in the event of the Participant’s Retirement, the Participant shall be paid (A) with respect to the pro-rata portion of Restricted Stock Units vested on his Retirement, within thirty (30) days of the Pro-rata Vesting Date, subject to a six month delay following the
Participant’s Retirement to the extent required by Section 409A of the Code, and (B) with respect to the remaining Restricted Stock Units, subject to compliance with Section 2(b), within thirty (30) days of the earlier of
the Vesting Date or a Change of Control; 
 (v)    in the event of the Participant’s Termination of Employment
without Cause or Termination of Employment for Good Reason (whether occurring on, before or after a Change of Control), the Participant shall be paid (A) with respect to the pro-rata portion of Restricted
Stock Units vested on his date of Termination of Employment, with thirty (30) days of the Pro-rata Vesting Date, subject to a six month delay following the Participant’s Termination of Employment to
the extent required by Section 409A of the Code, and (B) with respect to the remaining Restricted Stock Units, within thirty (30) days of the earlier of the Vesting Date or a Change of Control; 

(vi)    in the event of non-renewal of the Employment Agreement, the Participant
shall be paid within thirty (30) days of the Vesting Date. 
 3.    Change of Control Definition. For purposes of
this Agreement, a “Section 409A Change of Control” shall have the meaning set forth in Appendix A, attached hereto; provided, that, no event shall constitute a “Change of Control” for purposes of this Agreement unless such
event also qualifies as a “change in control event” for purposes of Treasury Regulation § 1.409A-3(i)(5). 

4.    Termination. Except as otherwise provided in Sections 2(b), 2(c), 2(d) and 2(e), all unvested Restricted Stock Units
will be forfeited on the Participant’s Termination of Employment. 
 5.    Dividend Equivalents. Cash dividends on
Shares shall be credited to a dividend book entry account on behalf of the Participant with respect to each Restricted Stock Unit granted to the Participant, provided that such cash dividends shall not be deemed to be reinvested in Shares and will
be held uninvested and without interest. The Participant’s right to receive any such cash dividends shall vest if and when the related Restricted Stock Unit vests, and such cash dividends shall be paid in cash to the Participant if and when the
related Restricted Stock Unit is paid to the Participant. Stock dividends on Shares shall be credited to a dividend book entry account on behalf of the Participant with respect to each Restricted Stock Unit granted to the Participant. The
Participant’s right to receive any such stock dividends shall vest if and when the related Restricted Stock Unit vests, and such stock dividends shall be paid in stock to the Participant if and when the related Restricted Stock Unit is paid to
the Participant. 
 6.    Rights as a Stockholder. The Participant shall have no rights as a stockholder with respect to
any Shares covered by any Restricted Stock Unit unless and until the Participant has become the holder of record of the Shares, and no adjustments shall be made for dividends in cash or other property, distributions or other rights in respect of any
such Shares, except as otherwise specifically provided for in this Agreement or the Plan. 
 7.    Provisions of
Plan Control. This Agreement is subject to all the terms, conditions and provisions of the Plan, including, without limitation, the amendment provisions thereof, and to such rules, regulations and interpretations relating to the Plan as may
be adopted by the Committee and as may be in effect from time to time. The Plan is incorporated herein by reference. Capitalized terms in this Agreement that are not otherwise defined shall have the same meaning as set forth in the Plan. If and to
the extent that this Agreement conflicts or is inconsistent with the terms, conditions and provisions of the Plan, the Plan shall control, and this Agreement shall be deemed to be modified accordingly. This Agreement contains the entire
understanding of the parties with respect to the subject matter hereof and supersedes any prior agreements between the Company and the Participant with respect to the subject matter hereof. 

  
 3 

 8.    Amendment. The Board or the Committee may amend, suspend or
terminate this Agreement subject to the terms of the Plan. Except as otherwise provided in the Plan, no modification or waiver of any of the provisions of this Agreement shall be effective unless in writing and signed by the party against whom it is
sought to be enforced. 
 9.    Notices. Any notice or communication given hereunder shall be in writing and shall be
deemed to have been duly given when delivered in person, or by regular United States mail, first class and prepaid, to the appropriate party at the address set forth below (or such other address as the party shall from time to time specify): 

If to the Company, to: 
 Henry
Schein, Inc. 
 135 Duryea Road 

Melville, New York 11747 

Attention: General Counsel 
 If to
the Participant, to the address on file with the Company. 
 10.    No Obligation to Continue Employment. This Agreement
is not an agreement of employment. This Agreement does not guarantee that the Company or its Subsidiaries will employ or retain, or to continue to, employ or retain the Participant during the entire, or any portion of the, term of this Agreement,
including but not limited to any period during which the Restricted Stock Unit is outstanding, nor does it modify in any respect the Company or its Subsidiary’s right to terminate the Participant’s employment or modify the
Participant’s compensation, except to the extent provided in the Participant’s Employment Agreement. 

11.    Legend. The Company may at any time place legends referencing any applicable federal, state or foreign securities law
restrictions on all certificates representing Shares issued pursuant to this Agreement. The Participant shall, at the request of the Company, promptly present to the Company any and all certificates representing Shares acquired pursuant to this
Agreement in the possession of the Participant in order to carry out the provisions of this Section 11. 
 12.    Securities
Representations. The grant of the Restricted Stock Units and issuance of Shares upon vesting of the Restricted Stock Units shall be subject to, and in compliance with, all applicable requirements of federal, state or foreign
securities law. No Shares may be issued hereunder if the issuance of such Shares would constitute a violation of any applicable federal, state or foreign securities laws or other law or regulations or the requirements of any stock exchange or market
system upon which the Shares may then be listed. As a condition to the settlement of the Restricted Stock Units, the Company may require the Participant to satisfy any qualifications that may be necessary or appropriate to evidence compliance with
any applicable law or regulation. 
 The Shares are being issued to the Participant and this Agreement is being made by the Company in
reliance upon the following express representations and warranties of the Participant. The Participant acknowledges, represents and warrants that: 

(a)    He or she has been advised that he or she may be an “affiliate” within the meaning of Rule 144 under the
Securities Act of 1933, as amended (the “Act”) and in this connection the Company is relying in part on his or her representations set forth in this section. 

(b)    If he or she is deemed an affiliate within the meaning of Rule 144 of the Act, the Shares must be held indefinitely
unless an exemption from any applicable resale restrictions is available or the Company files an additional registration statement (or a “re-offer prospectus”) with regard to such Shares and the
Company is under no obligation to register the Shares (or to file a “re-offer prospectus”). 

(c)    If he or she is deemed an affiliate within the meaning of Rule 144 of the Act, he or she understands that the
exemption from registration under Rule 144 will not be available unless (i) a public trading market then exists for the Common Stock of the Company, (ii) adequate information concerning the Company is then available to the public, and
(iii) other terms and conditions of Rule 144 or any exemption therefrom are complied with; and that any sale of the Shares may be made only in limited amounts in accordance with such terms and conditions. 

  
 4 

 13.    Transfer of Personal Data. The Participant authorizes,
agrees and unambiguously consents to the transmission by the Company of any personal data information related to the Restricted Stock Units awarded under this Agreement, for legitimate business purposes (including, without limitation, the
administration of the Plan) out of the Participant’s home country and including to countries with less data protection than the data protection provided by the Participant’s home country. This authorization/consent is freely given by the
Participant. 
 14.    Section 409A. Any provisions in this Agreement providing for the payment of “nonqualified
deferred compensation” (as defined in Section 409A of the Code and the Treasury regulations thereunder) to the Participant are intended to comply with the requirements of Section 409A of the Code, and this Agreement shall be
interpreted in accordance therewith. Neither party individually or in combination may accelerate or defer the timing of the payment of any such nonqualified deferred compensation, except in compliance with Section 409A of the Code and this
Agreement, and no amount shall be paid prior to the earliest date on which it is permitted to be paid under Section 409A of the Code and this Agreement. In no event whatsoever shall the Company be liable for any additional tax, interest or
penalty that may be imposed on the Participant as a result of Section 409A of the Code or any damages for failing to comply with Section 409A of the Code. Whenever a payment under this Agreement may be paid within a specified period, the
actual date of payment within the specified period shall be within the Company’s sole discretion. 

15.    Miscellaneous. This Agreement shall inure to the benefit of and be binding upon the parties hereto and their
respective heirs, legal representatives, successors and assigns. 
 (a)    This Agreement shall be governed and
construed in accordance with the laws of New York (regardless of the law that might otherwise govern under applicable New York principles of conflict of laws). 

  
 5 

 (b)    This Agreement may be executed in one or more counterparts, all
of which taken together shall constitute one contract. 
 (c)    The failure of any party hereto at any time to require
performance by another party of any provision of this Agreement shall not affect the right of such party to require performance of that provision, and any waiver by any party of any breach of any provision of this Agreement shall not be construed as
a waiver of any continuing or succeeding breach of such provision, a waiver of the provision itself, or a waiver of any right under this Agreement. 

IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the day and year first set forth above. 

 

	
	HENRY SCHEIN, INC.
	
	Michael S. Ettinger
	Senior Vice President, Corporate & Legal Affairs and Chief of Staff, Secretary
	
	Stanley M. Bergman
	
	  

  
 6 

 Appendix A 

This is Appendix A to the Restricted Stock Unit Agreement Pursuant to the Henry Schein, Inc. 2013 Stock Incentive Plan (As Amended and Restated Effective as
of May 14, 2013) (the “RSU Agreement”). For purposes of Section 3 of the RSU Agreement, a “Section 409A Change of Control” shall be deemed to have occurred upon: 

(i) an acquisition by any Person of beneficial ownership (within the meaning of Rule 13d-3 promulgated under the Act)
of (A) 50% or more of the then outstanding Shares or (B) 33% or more of the total combined voting power of the then outstanding voting securities of HSI entitled to vote generally in the election of directors (the “Outstanding HSI Voting
Securities”); excluding, however, the following: (w) any acquisition directly from the Company, other than an acquisition by virtue of the exercise of a conversion privilege unless the security being so converted was itself acquired
directly from the Company, (x) any acquisition by the Company, (y) any acquisition by an employee benefit plan (or related trust) sponsored or maintained by the Company or (z) any acquisition by any corporation pursuant to a
reorganization, merger, consolidation or similar corporate transaction (in each case, a “Corporate Transaction”), if, pursuant to such Corporate Transaction, the conditions described in clauses (A), (B) and (C) of paragraph
(iii) below are satisfied; or 
 (ii) within any 12-month period beginning on or after the date of the RSU
Agreement, the individuals who constitute the Board immediately before the beginning of such period (the Board as of the date hereof shall be hereinafter referred to as the “Incumbent Board”) cease for any reason to constitute at least a
majority of the Board; provided that for purposes of this Subsection any individual who becomes a member of the Board subsequent to the date hereof whose election, or nomination for election by HSI’s stockholders, was approved by a vote of at
least a majority of those individuals who are members of the Board and who are also members of the Incumbent Board (or deemed to be such pursuant to this proviso) shall be considered as though such individual were a member of the Incumbent Board;
but, provided further, that any such individual whose initial assumption of office occurs as a result of either an actual or threatened election contest (as such terms are used in Rule 14a-11 of Regulation 14A
promulgated under the Act) or other actual or threatened solicitation of proxies or consents by or on behalf of a Person other than the Board shall not be so considered as a member of the Incumbent Board; or 

(iii) the consummation of a Corporate Transaction; excluding, however, such a Corporate Transaction pursuant to which (A) all or substantially all of the
individuals and entities who are the beneficial owners, respectively, of the outstanding Shares and Outstanding HSI Voting Securities immediately prior to such Corporate Transaction will beneficially own, directly or indirectly, more than 60% of,
respectively, the outstanding shares of common stock of the corporation resulting from such Corporate Transaction and the combined voting power of the outstanding voting 

  
 7 

 
securities of such corporation entitled to vote generally in the election of directors, in substantially the same proportions as their ownership, immediately prior to such Corporate Transaction,
of the outstanding Shares and Outstanding HSI Voting Securities, as the case may be, (B) no Person (other than the Company, any employee benefit plan (or related trust) of the Company or the corporation resulting from such Corporate Transaction
and any Person beneficially owning, immediately prior to such Corporate Transaction, directly or indirectly, 33% or more of the outstanding Shares or Outstanding HSI Voting Securities, as the case may be, will beneficially own, directly or
indirectly, 33% or more of, respectively, the outstanding shares of common stock of the corporation resulting from such Corporate Transaction or the combined voting power of the then outstanding securities of such corporation entitled to vote
generally in the election of directors and (C) individuals who were members of the Incumbent Board will constitute at least a majority of the members of the board of directors of the corporation resulting from such Corporate Transaction; or

 (iv) the sale or other disposition of all or substantially all of the assets of the Company; excluding, however, such sale or other disposition to a
corporation with respect to which, following such sale or other disposition, (x) more than 60% of, respectively, the then outstanding shares of common stock of such corporation and the combined voting power of the then outstanding voting
securities of such corporation entitled to vote generally in the election of directors will be then beneficially owned, directly or indirectly, by all or substantially all of the individuals and entities who were the beneficial owners, respectively,
of the outstanding Common Stock and Outstanding HSI Voting Securities immediately prior to such sale or other disposition in substantially the same proportion as their ownership, immediately prior to such sale or other disposition, of the
outstanding Common Stock and Outstanding HSI Voting Securities, as the case may be, (y) no Person (other than the Company and any employee benefit plan (or related trust) of the Company or such corporation and any Person beneficially owning,
immediately prior to such sale or other disposition, directly or indirectly, 33% or more of the outstanding Common Stock or Outstanding HSI Voting Securities, as the case may be) will beneficially own, directly or indirectly, 33% or more of,
respectively, the then outstanding shares of common stock of such corporation and the combined voting power of the then outstanding voting securities of such corporation entitled to vote generally in the election of directors and
(z) individuals who were members of the Incumbent Board will constitute at least a majority of the members of the board of directors of such corporation. 

(v) No event set forth herein shall constitute a “Section 409A Change of Control” unless such event also qualifies as a “change in control
event” for purposes of Treasury Regulation § 1.409A-3(i)(5). Accordingly, the definition of “Section 409A Change of Control” set forth herein shall be limited, construed and
interpreted in accordance with Section 409A and the regulations issued thereunder. 

  
 8 

 Exhibit B 

FORM OF GENERAL RELEASE 

 EXHIBIT B 

RELEASE1 

1. RELEASE AND WAIVER 
 (a) Claims Released:
In return for the severance and/or other benefits that I will receive pursuant to my Amended and Restated Employment Agreement, by and between me and the Henry Schein, Inc. (“HSI” or the “Company”), dated effective as of
August 8, 2019 (the “Employment Agreement”), I agree to completely and irrevocably release all claims, obligations, causes of action and demands which I have or ever had, from the beginning of time to the date I sign this release of
claims (the “Release”, “General Release”, or “Agreement”) against the Company, its parents, subsidiaries, divisions, joint ventures, partnerships and/or affiliated entities, their predecessors, successors and assigns,
and all of their present and/or former officers, directors, managers, supervisors, employees, shareholders, agents, representatives, and employee benefit or pension plans or funds (and the trustees, administrators, fiduciaries and insurers of such
programs) (collectively, the “Released Parties”) relating to my employment with, or termination of employment from, the Company and its subsidiaries. I agree that any person acting by, through or under me, such as my spouse, heirs,
executors, representatives and assigns, are also bound by my release of claims. 
 I understand that I am releasing the Released Parties from any and all
claims and potential claims to the extent they may be legally waived by private agreement, including but not limited to: (i) any claims under Title VII of the Civil Rights Act of 1964, the Civil Rights Act of 1866, the Civil Rights Act of 1991,
the Americans With Disabilities Act, the Age Discrimination in Employment Act of 1967, the Equal Pay Act, the Family Medical Leave Act, the National Labor Relations Act, the Pregnancy Discrimination Act, the Employee Retirement Income Security Act
of 1974, Sections 503 and 504 of the Rehabilitation Act of 1973, the Worker Adjustment Retraining and Notification Act, the Immigration Reform and Control Act, the Genetic Information Non-Discrimination Act,
the Sarbanes Oxley Act of 2002, the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010, all as amended; (ii) any claims under any State or Municipal Human Rights Laws, labor laws and/or discrimination laws, and all other federal,
state and local discrimination, labor or employment laws, regulations or orders; (iii) any other claims relating to or arising out of my employment, the terms and conditions of my employment and/or the termination of my employment, including
but not limited to statutory claims and claims in common law or in equity, including, without limitation, claims for discrimination, retaliation, harassment, whistle-blowing, breach of contract or of policy or practice, constructive discharge,
wrongful discharge, detrimental reliance, negligence, emotional distress, and all torts, 
   

 

	1 	 Release should be revised to reflect (i) changes in law or interpretations or as otherwise necessary to assure
enforceability or tax effectiveness, and/or (ii) 45 day period in lieu of 21 day period and OWBPA disclosure (i.e., in the event Bergman’s termination occurs at the same time as other terminations), if applicable. 

  

			
	Stanley Bergman	  	Page - 1 - of 12

 
including any intentional torts, such as defamation; (iv) any claims subject to federal, state and local occupational safety and health laws and regulations; (v) any claims under any
other federal, state or local Constitution, statute, regulation, or agreement or duty; (vi) any claims concerning or based on the adequacy of my compensation or remuneration, including incentive payments, or claims for benefits, including but
not limited to claims under the Fair Labor Standards Act, to the extent such claims are waivable; and (vii) any claims for damages or relief of any kind, including but not limited to front pay, back pay, damages for pain and suffering,
compensatory or punitive damages, injunctive or declaratory relief, any claims for attorneys’ fees, costs, disbursements and/or the like, or for equitable relief and reinstatement. 

I also waive and release any right to become, and promise not to consent to become, a member of any class or collective action in a case in which claims are
asserted against the Released Parties that are related in any way to my employment or the termination of my employment with the Company. If, without my prior knowledge and consent, I am made a member of a class in any such legal proceeding or
arbitration, I agree to opt out of the class at the first opportunity. 
 (b) Unknown Claims: I understand that I am releasing all claims, whether or
not they are known to me at the time I sign this Release. 
 (c) Claims Not Waived: This Release does not apply to any claims or rights (i) that
may arise after the date that I signed this release, (ii) for the consideration for (including the severance payments due under the Employment Agreement) or breach of this Release, (iii) for reimbursement of business expenses incurred on
behalf of the Company under the Company’s expense reimbursement policies, (iv) for vested rights I may have under the Company’s ERISA-covered employee benefit plans (or any other employee benefit or deferred compensation plans) on the
date I sign this Release, in each case, in accordance with the terms and conditions of the applicable plans, (v) to be indemnified or advanced fees and costs for claims related to my acts or omissions as an officer or director to the maximum
extent permitted by law and the Company’s controlling documents, including, but not limited to, under the Indemnification Agreement that I executed, dated as of November 4, 2015, and to be covered under the applicable directors’ and
officers’ liability insurance plans or policies of the Company or its subsidiaries related to my acts or omissions as an officer or director, in each case, in accordance with the terms and conditions of the applicable documents, plans, and/or
policies, (vi) any claims that controlling law clearly states may not be released by private settlement, such as, but not limited to, claims for Worker’s Compensation benefits for job-related illness
or injury or for unemployment compensation, (vii) in respect of my outstanding equity awards, which shall remain subject to and be treated in accordance with the terms of the award agreement(s) and governing plan document(s) applicable to such
awards, (viii) in respect of my rights as a shareholder of the Company and/or (ix) to challenge the validity of this General Release under the Older Workers Benefit Protection Act (OWBPA). 

  

			
	Stanley Bergman	  	Page - 2 - of 12

 I also understand that nothing in this Agreement, including but not limited to the provisions regarding
the release and waiver of claims in Section 1, the “no claims” provisions of Section 4, the cooperation provisions in Section 5, the confidentiality/non-solicitation provisions in
Section 6, or the non-disparagement provisions in Section 8, prevents me from filing a charge or complaint with, cooperating with or providing information to, or voluntarily participating in an
investigation or proceeding conducted by, the Equal Employment Opportunity Commission (EEOC), the National Labor Relations Board (NLRB), the U.S. Department of Labor (DOL), Securities and Exchange Commission (SEC), the Occupational Safety and Health
Administration (OSHA), or any other federal, state or local agency or entity charged with the enforcement of any laws, any self-regulatory body or any law enforcement authority (a “Government Entity”), including providing documents or
other information, from testifying truthfully in the course of any administrative, legal or arbitration proceeding, reporting possible violations of federal and/or state law or regulations, including possible securities law violations to any
Government Entity or making any other disclosures that are protected under the whistleblower provisions of any federal and/or state whistleblower programs. However, by signing this General Release I am waiving my right to individual relief based on
claims asserted in such a charge or complaint, regardless of whether I or another party has filed it, to the extent allowed by law, and agree that the severance I will receive as provided in this Agreement fully and completely satisfies any and all
such claims, except for any right that I may have to receive a payment from a government agency (and not the Company) for information provided to the government agency. Additionally, I acknowledge and understand that under the Federal Defend Trade
Secrets Act of 2016, I will not be held criminally or civilly liable under any federal or state trade secret law for the disclosure of a trade secret that is made: (i)(A) in confidence to a federal, state or local government official, either
directly or indirectly, or to an attorney, and (B) solely for the purpose of reporting or investigating a suspected violation of law; (ii) to my attorney in relation to a lawsuit for retaliation against me for reporting a suspected
violation of law; or (iii) in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal. 
 I also
understand that nothing in this Agreement, including the sections listed above, shall be interpreted or enforced in a manner that would interfere with my rights under the National Labor Relations Act, if any, to engage in protected concerted
activity with other employees. 

  

			
	Stanley Bergman	  	Page - 3 - of 12

 2. SEVERANCE 

In return for my (i) remaining employed by the Company until the last day my services are required (my “Termination Date”) – [●],
(ii) signing this Release no earlier than my Termination Date, (iii) not revoking this Release, (iv) complying in all respects with the terms and conditions of this Release and/or the Employment Agreement restricting competition, and
prohibiting solicitation of employees and/or customers, (v) complying in all respects with the terms and conditions of this Release and/or the Employment Agreement concerning the nondisclosure of confidential and/or proprietary information, and
(vi) observing all other terms and conditions of this Agreement and/or the Employment Agreement in all material respects, the Company will provide me with those payment and benefits set forth in Sections [●]2 of the Employment Agreement, subject to the terms and conditions set forth in the Employment Agreement, all regular and customary payroll deductions, and Sections 9 and 12(i) of this Release. I
understand that whether I sign this Agreement or not, I must return all Company property, including mobile devices, keys, identity cards, and Company files and records in whatever form; and any payment to me under this Section is contingent on my
doing so other than with respect to immaterial failures to do so. In order for me to be deemed in violation of (i) subclauses (v) or (vi) of the first sentence of this Section 2, or (ii) the immediately preceding sentence, the
Company must provide me with written notice of the facts and circumstances alleged to constitute such violation and not less than 30 days to cure such violation, in each case, if and to the extent such violation is curable (such notice and
opportunity to cure, the “Cure Right”). Notwithstanding the foregoing, I may retain my contacts, calendars and personal correspondence and any information reasonably needed for my personal tax return preparation purposes, in each case, to
the extent such contacts, calendars, correspondence and/or information does not contain Confidential Information (as defined below). 
 3.
REVOCATION 
 I understand that if I sign this Release, I can change my mind and revoke it within seven (7) days after signing it by sending
a written revocation notice to the Senior Vice President, Global Human Resources and Financial Operations, Henry Schein, Inc. (“SVP, HR”), 135 Duryea Road, Melville, NY 11747. I understand that the Release and waiver set forth above will
not be effective until after this seven-day period has expired (the “Revocation Period”) and the Company has also signed this Agreement, and I will receive no benefits before the Agreement becomes
effective. 
  

	2 	 Employment Agreement section references will depend on type and timing of termination of employment.

  

			
	Stanley Bergman	  	Page - 4 - of 12

 To be effective, (a) the notice of revocation must be received by SVP, HR no later than the seventh day
after I have signed the Agreement, or else (b) SVP, HR must be notified by e-mail ([●]3) or facsimile ([●]3) by seventh calendar day after I have signed the Agreement, that I am revoking this Agreement. If any of those days should fall on a weekend or a legal holiday, then the required communication must
be received no later than the first business day after the weekend or holiday. 
 4. NO CLAIMS AGAINST THE COMPANY 

Except as provided in Section 1(c) above, I promise that I will not pursue any claim that I have settled by this Release. If I break this promise, I agree
to pay all of the Company’s costs and expenses (including reasonable attorneys’ fees) related to the defense of any claims. This paragraph does not apply to claims that I may have under the Age Discrimination in Employment Act of 1967
(“ADEA”). Such claims are covered by the next paragraph. 
 Although I am releasing claims that I may have under the ADEA, I understand that I may
challenge the knowing and voluntary nature of this Release under the Older Workers Benefit Protection Act (“OWBPA”) and the ADEA. I understand, however, that if I pursue a claim against the Company under the OWBPA and/or the ADEA, a court
has the discretion to determine whether the Company is entitled to restitution, recoupment, or set off (meaning “reduction”) against a monetary award obtained by me in the court proceeding. A reduction never can exceed the amount I
recover, or the severance I received for signing this General Release, whichever is less. I also recognize that the Company may be entitled to recover costs and attorneys’ fees incurred by the Company as specifically authorized under applicable
law. 
 I further understand that nothing in this Release prevents me from filing a charge or complaint with or from participating in an investigation or
proceeding conducted by the Equal Employment Opportunity Commission (EEOC), National Labor Relations Board (NLRB), the U.S. Department of Labor, or any other federal, state or local agency charged with the enforcement of any laws, although by
signing this General Release I am waiving my right to individual relief based on claims asserted in such a charge or complaint, whether filed by me or any other person or group. 

5. COOPERATION; RESIGNATION  
 Except as provided
in Section 1(c), I agree, after my Termination Date, to reasonably cooperate with the Company in providing and discussing facts pertaining to matters which occurred during my employment (for example, in connection with lawsuits or governmental
investigations) and I agree to make myself reasonably available for interviews without the necessity for a subpoena by 
  

	3 	 Insert correct information prior to providing this Agreement to Bergman. 

  

			
	Stanley Bergman	  	Page - 5 - of 12

 
the Company, provided, that any such cooperation shall be subject to my reasonable business and personal commitments at such time. The Company shall promptly reimburse me for any reasonable
expenses incurred in connection with such cooperation (including reasonable legal fees and expenses incurred if the Company and I reasonably agree that separate counsel is appropriate because the Company’s counsel cannot represent me due to a
conflict of interests) with travel expenses reimbursed commensurate with the Company’s current practice, subject to the Company’s executive travel policy in effect as of the effective date of the Employment Agreement. I acknowledge and
agree that I continue to be bound by all obligations regarding the preservation of documents contained in all litigation hold notices issued to me by the Company. On and after my Termination Date, I shall be deemed to have resigned from all titles,
positions and appointments that I hold with the Company, whether as an officer, director, employee, consultant, trustee, committee member, agent or otherwise and I agree to promptly execute such documents as the Company, in its sole discretion,
shall reasonably deem necessary to effect such resignation. 
 6.
CONFIDENTIALITY/NON-SOLICITATION/NON-COMPETITION 
 (a) Except as
provided in Section 1(c), I agree that I continue to be bound by any and all obligations concerning the nondisclosure of confidential and/or proprietary information, restricting competition with the Company, prohibiting solicitation of
employees and/or customers, and/or assigning intellectual property contained in any agreements I have entered into with the Company or in any of the Company’s Personnel Manuals or Policy Statements that were applicable to me or as required by
applicable law, including, but not limited to, the obligations set forth in the Employment Agreement. I specifically agree to comply with the provisions concerning Sensitive and Confidential Information set forth in the Company’s Worldwide
Business Standards, which shall continue to apply following the date hereof, and not to disclose or utilize or utilize on behalf of any third party, the Company’s confidential and/or proprietary information. 

(b) Without limiting or modifying my promises in the previous paragraph, I agree that I have a continuing obligation not to disclose any confidential and/or
proprietary information acquired or developed during my employment with the Company (sometimes referred to herein as “Confidential Information”). Generally, any information which has not been announced in mailings, published in magazines
or newspapers, or made public in some other way is considered confidential. Certain other information is also considered confidential. Although the following list is not exhaustive, it highlights some examples of the types of information that must
not be disclosed: operating and strategic plans; internal client lists; pricing policies; financial data such as sales volumes, profit margins, price quotations, sales costs, nonpublic sales volumes, market studies; marketing plans; new or existing
processes or product development; regulatory information and communications; acquisition or joint ventures involving technology, software or other matters; potential transactions; internal company telephone lists and address books; and information
concerning new services or potential new services. 

  

			
	Stanley Bergman	  	Page - 6 - of 12

 (c) Notwithstanding anything contained in this Release to the contrary, I may disclose confidential and/or
proprietary information: (i) if required to do so by law or a court; (ii) in good faith solely to the minimum extent directly related to and (A) reasonably necessary to implement this Release or to enforce the Release or any of its
terms, or (B) in connection with any litigation between the Company or any of its affiliates and me, provided that, in each case, I shall take all actions necessary to ensure that such disclosure shall be made under seal; (iii) to a
government agency, as allowed by paragraph 1(c) of this Release and (iv) to my attorneys, accountants and/or tax advisors in order to obtain professional advice within the scope of their representation, provided that they shall first agree to
keep such information confidential. 
 (d) In addition, I am not permitted to disclose any legally privileged information (whether oral, written, or in
other tangible form), such as communications subject to the Attorney-Client privilege or Attorney-Work Product Doctrine and I will not do so. 
 (e) I
further agree that the restrictive covenant provisions set forth in Section 6 of the Employment Agreement shall remain in full force and effect and shall continue to apply following the date hereof. 

7. RETURN OF COMPANY PROPERTY 
 By signing below, I
represent that, except as permitted by Section 1(c), I have (i) returned to the Company any and all Confidential Information and all other materials, documents or property belonging to the Company or any of its affiliated entities,
including without limitation, files, documents, lists, pricing policies, financial and other data such as sales volumes, profit margins, price quotations, sales costs, market studies, client lists, marketing plans, new or existing processes or
product development, regulatory information and communications, acquisition or joint ventures involving technology, software or other matters, information concerning new services or potential new services, records, manuals, reports, software and
hardware, laptops, printers, computers, cell phone, blackberry, keys, equipment, identification cards, access card, credit cards, mailing lists, rolodexes, personnel information, electronic information and files, computer print-outs, and computer
disks and tapes, (ii) not retained any copies of any Confidential Information and/or any other materials, documents, data or property belonging to the Company or any of its affiliated entities, and (iii) permanently deleted all
Confidential Information from my home and/or personal computer drives and from any other personal electronic, digital or magnetic storage devices. Notwithstanding the foregoing, I may retain my contacts, calendars and personal correspondence and any
information reasonably needed for my personal tax return preparation purposes, in each case, to the extent such contacts, calendars, correspondence and/or information does not contain Confidential Information. 

  

			
	Stanley Bergman	  	Page - 7 - of 12

 8. NON-DISPARAGEMENT 

Except as otherwise permitted in Section1(c), I agree that I shall not make, directly or indirectly, to any person or entity including, but not limited to,
present or former employees of the Company and/or the press, any disparaging oral or written statements about the Company or its affiliates or their employees or directors, their products or services or customers, or my employment with or separation
from employment with the Company, or intentionally do anything which damages the Company, its affiliates, and/or their services, reputation, financial status, or business relationship orally, in writing, or on any social networking sites, including
but not limited to Facebook, Instagram, and LinkedIn; to any microblogging sites, including but not limited to Twitter; to any personal website or blog; video sharing or hosting websites, including but not limited to YouTube; and from e-mailing to any distribution list or list-serve to which I may subscribe, or which I maintain or moderate. The Company shall instruct its directors and officers not to make, directly or indirectly, any disparaging
statements about me orally, in writing, or on any social networking sites. This paragraph shall not prevent me from testifying truthfully under oath pursuant to a valid and enforceable subpoena, court order and/or similar process from a judicial,
arbitral, administrative or regulatory body of competent jurisdiction or in the case of a litigation or arbitration between the Company or any of its affiliates and me (provided that my statements shall be made in good faith and solely to the
minimum extent directly related to and reasonably necessary in connection with such litigation or arbitration, and I shall take all actions necessary to ensure that such statements shall be made under seal), or from filing a charge or voluntarily
participating in a government investigation as provided in paragraph 1(c). Nothing in this paragraph or elsewhere in this Agreement shall prevent me from exercising any rights I may have under the National Labor Relations Act to disclose or comment
upon my terms and conditions of employment. 
 9. BREACH OF AGREEMENT  

I acknowledge that the Company would be irreparably injured by a violation by me of paragraphs 5, 6, 7 and/or 8. I agree that in the event of any such breach
or threatened breach, the Company shall, in addition to any other remedies available to it, be entitled to seek a temporary restraining order and/or preliminary and/or permanent injunction, or other equivalent relief, restraining me from any actual
or threatened breach of paragraphs 5, 6, 7 and/or 8. Nothing in this Release shall limit or prevent the Company from also pursuing any other or additional remedies it may have for breach of this and/or any other agreement I may have signed,
including without limitation, return of all or partial severance payments in the event that I materially breach this Agreement or the Employment Agreement. For purposes of this Section 9, the Company and I hereby agree and acknowledge

  

			
	Stanley Bergman	  	Page - 8 - of 12

 
that (i) any breach of any terms and conditions of this Release and/or the Employment Agreement restricting competition, or prohibiting solicitation of employees and/or customers shall be
deemed to be a material breach and shall not be subject to a Cure Right, (ii) any breach of any terms and conditions of this Release and/or the Employment Agreement concerning the nondisclosure of confidential and/or proprietary information
shall be deemed to be a material breach, but, to the extent curable, shall be subject to a Cure Right, and (iii) any breach of any of the other terms and conditions of this Release and/or the Employment Agreement, to the extent curable, shall
be subject to a Cure Right. 
 10. VOLUNTARY AGREEMENT: ADVICE OF COUNSEL: 21 DAY PERIOD 

I acknowledge that: 
 (a)    I have read this
entire document, and I fully understand it. I understand its legal and binding effect, and, except as otherwise provided in paragraph 1(c) of this Agreement, by signing it I give up certain rights, including my right to pursue any claims I had, have
or may have had, whether known or unknown, against the Released Parties. I am acting voluntarily and of my own free will in signing this Release. 

(b)    The benefits HSI is providing me in return for signing this Release are in addition to anything of value to which I already am
entitled. Specifically, I acknowledge that I am not otherwise entitled to severance or other benefits, whether set forth in Sections [●] of the Employment Agreement or otherwise. 

(c)    I have had the opportunity to seek, and I was and am advised in writing to seek, legal counsel prior to signing this Release. 

(d)     The benefits which the Company is agreeing to provide me under this Release are sufficient consideration for my undertakings in
this Release, including but not limited to the release of claims in Section 1, the cooperation provisions in Section 5, the confidentiality provisions in Section 6, and the non-disparagement
provisions in Section 8. 
 (e)    I have been given at least 21 days to consider the terms of this Release before signing it. If I
have signed this Release before the full 21 days expired, I knowingly and voluntarily waive the remainder of the 21-days to consider whether to sign this Release. The Company has not threatened me or promised
me any benefit to induce me to sign this release before the end of the full 21-day period. 

(f)    I agree with the Company that changes to this Release, whether material or immaterial, do not restart the running of the 21-day consideration period. 

  

			
	Stanley Bergman	  	Page - 9 - of 12

 (g)    I understand that this Release will be void and the Company shall have no
obligation to provide me severance benefits if I sign this Release prior to my Termination Date, and I agree to that condition. I also understand that this Release will be void if I do not sign it within the 21 day period stated above, or if I
revoke it. 
 (h)    This Release shall not be construed to be an admission by the Released Parties of any liability or wrongdoing or a
violation of any statute, regulation, duty, law, contract, right or order. The Released Parties disclaim any liability to me or any other person for any alleged violation of any statute, regulation, duty, law, contract or order. 

(j)    I have (i) received all compensation due me as a result of services performed for the Company; (ii) reported to the
Company any and all work-related injuries incurred by me during my employment by the Company; and (iii) been properly provided any leave of absence because of my or a family member’s health condition or military service and have not been
subjected to any improper treatment, conduct or actions due to a request for or taking such leave. I am not aware of any uncured ethical or compliance issues involving the Company or any of its employees, and have not reported any such issues to the
Company. 
 12. GENERAL PROVISIONS 

(a) Governance. This Release shall be governed by New York law, except as it may be preempted by federal law. 

(b) Entire Agreement. This Release constitutes the complete and total agreement between the Company and me with respect to
issues addressed in this Release. However, I agree this Release shall not in any way affect, modify, or nullify any obligation which I have to protect the Company’s confidential information, or to refrain from competing with the Company, or
soliciting Company employees or customers after my employment is terminated and/or to assign intellectual property to the Company, contained in any agreement(s) I have entered into with the Company, and that such obligations contained in those
agreement(s) remains in full force and effect, including, but not limited to, the Employment Agreement. I understand and agree that effective as of the Termination Date, for purposes of the Employment Agreement, (i) the “Employment
Period” (as defined therein) shall be terminated, (ii) the restrictive covenants set forth in Section 6 of the Employment Agreement shall continue to apply to me in accordance with the terms thereof, and (iii) Section(s)
[●] of the Employment Agreement (governing severance and/or post-termination benefits) shall continue to apply. 
 (c)
Amendment. No provision in this Release may be amended unless such amendment is agreed to in writing and signed by both me and an authorized officer of the Company. 

  

			
	Stanley Bergman	  	Page - 10 - of 12

 (d) Non-Reliance. I represent that in
signing this Release, I am not relying on any other agreements or representations not fully expressed in this document. This Release shall not be modified, altered or discharged except by written agreement signed by an authorized Company
representative and me. 
 (e) Headings. The headings in this document are for reference only, and shall not in any way affect
the meaning or interpretation of this release. 
 (f) Use of Release in Subsequent Proceedings. I further agree that
this document may be used as evidence in a subsequent proceeding in which the Company or I allege a breach of this Release or as a complete defense to any lawsuit or claim. Other than this exception, or disclosure to the EEOC or NLRB or any other
federal, state or local agency charged with the enforcement of any employment laws, as provided in Section 1(c) above, I agree I will not offer or introduce this Release as evidence in any administrative proceeding, arbitration or lawsuit. 

(g) Enforcement. The failure of either party to insist upon strict adherence to any term of this Release shall not be
considered a waiver of that term or of any other term of this Release, and shall not deprive that party of the right to later insist upon strict adherence to that term or any other term of the Agreement. Any waiver must be in writing and signed by
me or an authorized officer of the Company, as the case may be. 
 (h) Severability. The parties agree that should any part of
this Release be found to be void or unenforceable by a court of competent jurisdiction, that determination will not affect the remainder of this Release. Should a court of competent jurisdiction find that any of the restrictions as written herein,
is excessive and goes beyond what is permitted by law, we agree that the court shall revise the restriction to the extent necessary to achieve lawful enforcement and shall enforce the provisions as so revised. 

(i) Tax matters. The Company may withhold from any amounts payable under this Release such federal, state and local taxes
as may be required to be withheld under any applicable law or regulation, as determined by the Company and its advisors. The Company agrees that it is the intent of the parties that all compensation and benefits payable or provided to me (whether
under this Release or otherwise) shall fully comply with, or be exempt from, the requirements of Section 409A of the Internal Revenue Code of 1986, as amended (“Code Section 409A”). In the event the parties agree that the payment
of compensation or benefits to me would be in violation of Code Section 409A, the parties shall in good faith cooperate to attempt to modify any such payments in order to comply with Code Section 409A while preserving the intended economic
benefits. In no event whatsoever shall the Company be liable for any additional tax, interest or penalty that may be imposed on you pursuant to Code Section 409A or any damages for failing to comply with Code Section 409A. Notwithstanding
anything 

  

			
	Stanley Bergman	  	Page - 11 - of 12

 
contained in this Release to the contrary, each and every payment made under this Release shall be treated as a separate and distinct payment and not as a series of payments. I agree and
acknowledge that in no event shall I designate the tax year of the commencement of any payment or benefit and that the Company will determine the actual commencement date of payment of any payments or benefits hereunder. Notwithstanding the
foregoing or anything else contained in this Release to the contrary, if I am a “specified employee” (determined in accordance with Code Section 409A and Treasury Regulation
Section 1.409A-3(i)(2)) as of the Termination Date, and if any payment, benefit or entitlement provided for in this Release both (i) constitutes a “deferral of compensation” within the
meaning of Code Section 409A and (ii) cannot be paid or provided in a manner otherwise provided herein or otherwise without subjecting me to additional tax, interest and/or penalties under Code Section 409A, then any such payment,
benefit or entitlement that is payable during the first 6 months following the date of my separation from service shall be paid or provided to me in a lump sum cash payment to be made on the earlier of (x) my death or (y) the first
business day of the seventh calendar month immediately following the month in which the separation from service occurs.  
 (j)
Counterparts. This Release may be executed in two or more counterparts, and such counterparts shall constitute one and the same instrument. Signatures delivered by facsimile or email shall be deemed effective for all purposes to the extent
permitted under applicable law. 
 Notice: Should you need further explanation of this Release, please do not hesitate to contact SVP, HR (phone:
[●]4; fax: [●]4; email: [●]4). We have enclosed two copies of this
Release. If you are in agreement with terms outlined herein, kindly sign both copies no earlier than your Termination Date and return them to SVP, HR. 

I have read and understand the Release set forth above. I accept the consideration stated above and agree to be bound by the terms of this Release.

  

	
	  

	Stanley M. Bergman
	Dated:
	
	Agreed to:
	
	  

	Name
	Title
	Dated:

  

	4 	 Insert correct information prior to providing this Agreement to Bergman. 

  

			
	Stanley Bergman	  	Page - 12 - of 12

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00298-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00298-of-00352.parquet"}]]